Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	TBC1D9B NBPF26 CDHR5 RYR1 RYR2 NELL1 FAT1 HMCN2 RASGRP3 USP32 GPD2 FAT4 COMP PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CRTAC1 MYOF THBS3 CELSR3 CELSR2 PCDHGA12 ANXA10 DCHS1 PCDH1 CDH5	5.91e-08	749	219	27	GO:0005509
GeneOntologyMolecularFunction	SUMO ligase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.06e-06	20	219	5	GO:0061665
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RGPD4 TBC1D9B NET1 RGPD1 RASGRP3 HPS4 RGPD3 SERGEF TNS3 ARAP1 RGPD5 RANBP2 RGPD8 RASGEF1A ARHGEF25 RGS12 SBF2 KNDC1 DEPDC5	3.47e-06	507	219	19	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RGPD4 TBC1D9B NET1 RGPD1 RASGRP3 HPS4 RGPD3 SERGEF TNS3 ARAP1 RGPD5 RANBP2 RGPD8 RASGEF1A ARHGEF25 RGS12 SBF2 KNDC1 DEPDC5	3.47e-06	507	219	19	GO:0030695
GeneOntologyMolecularFunction	SUMO transferase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	4.33e-05	36	219	5	GO:0019789
GeneOntologyMolecularFunction	choline-phosphate cytidylyltransferase activity	PCYT1A PCYT1B	1.20e-04	2	219	2	GO:0004105
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.15e-04	50	219	5	GO:0003755
GeneOntologyMolecularFunction	GTPase activator activity	RGPD4 TBC1D9B RGPD1 RASGRP3 RGPD3 ARAP1 RGPD5 RANBP2 RGPD8 RGS12 DEPDC5	2.71e-04	279	219	11	GO:0005096
GeneOntologyMolecularFunction	isomerase activity	RGPD4 RGPD1 PGM3 RGPD3 PDIA5 L3HYPDH RANBP2 RGPD8 MMUT	2.78e-04	192	219	9	GO:0016853
GeneOntologyMolecularFunction	cis-trans isomerase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.84e-04	53	219	5	GO:0016859
GeneOntologyMolecularFunction	RNA polymerase III general transcription initiation factor binding	ZBTB43 OPTN	7.08e-04	4	219	2	GO:0001025
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2	7.08e-04	4	219	2	GO:0005219
GeneOntologyMolecularFunction	glutaminase activity	GLS2 CAD	7.08e-04	4	219	2	GO:0004359
GeneOntologyMolecularFunction	voltage-gated potassium channel activity	KCNV2 KCNA1 KCNA10 KCND1 KCNT2 KCNAB3	9.12e-04	102	219	6	GO:0005249
GeneOntologyMolecularFunction	protein decrotonylase activity	SIRT1 HDAC1	1.17e-03	5	219	2	GO:0160008
GeneOntologyMolecularFunction	histone decrotonylase activity	SIRT1 HDAC1	1.17e-03	5	219	2	GO:0160009
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	RGPD4 RGPD1 KPNA6 RGPD3 KPNA1 RGPD5 RANBP2 RGPD8	1.66e-11	20	220	8	GO:0006607
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CDHR5 FAT1 HMCN2 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 NECTIN3 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.66e-09	187	220	15	GO:0007156
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.61e-08	9	220	5	GO:0033133
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	3.18e-08	10	220	5	GO:1903301
GeneOntologyBiologicalProcess	regulation of glucokinase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.58e-07	13	220	5	GO:0033131
GeneOntologyBiologicalProcess	regulation of hexokinase activity	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.44e-07	14	220	5	GO:1903299
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CDHR5 FAT1 HMCN2 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 NECTIN3 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.46e-06	313	220	15	GO:0098742
GeneOntologyBiologicalProcess	regulation of carbohydrate biosynthetic process	RGPD4 RGPD1 IRS1 NFKB1 RGPD3 RANBP2 RGPD8 SIRT1 PPP1R3A	1.24e-05	132	220	9	GO:0043255
GeneOntologyBiologicalProcess	establishment of protein localization to organelle	RGPD4 RGPD1 SRP72 KPNA6 RYR2 PIK3R4 SQSTM1 HPS4 RGPD3 VPS13A MKLN1 KPNA1 RGPD5 RANBP2 RGPD8 NUP98 VPS13D	4.08e-05	515	220	17	GO:0072594
GeneOntologyBiologicalProcess	protein import into nucleus	RGPD4 RGPD1 KPNA6 SQSTM1 RGPD3 KPNA1 RGPD5 RANBP2 RGPD8 NUP98	4.84e-05	195	220	10	GO:0006606
GeneOntologyBiologicalProcess	protein peptidyl-prolyl isomerization	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	4.97e-05	38	220	5	GO:0000413
GeneOntologyBiologicalProcess	import into nucleus	RGPD4 RGPD1 KPNA6 SQSTM1 RGPD3 KPNA1 RGPD5 RANBP2 RGPD8 NUP98	6.25e-05	201	220	10	GO:0051170
GeneOntologyBiologicalProcess	response to caffeine	IRS1 RYR1 RYR2 CAD	6.54e-05	21	220	4	GO:0031000
GeneOntologyBiologicalProcess	cell-cell adhesion	ILDR2 HLA-DOA PIEZO1 CDHR5 GCNT2 ITGA9 FAT1 HMCN2 PLEKHA7 DPP4 FAT4 COMP PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 NECTIN3 IGDCC4 CELSR3 CELSR2 PCDHGA12 TJP1 DCHS1 PCDH1 CDH5 TNXB	8.75e-05	1077	220	26	GO:0098609
GeneOntologyBiologicalProcess	regulation of glucose metabolic process	RGPD4 ACACB RGPD1 IRS1 RGPD3 RANBP2 RGPD8 SIRT1	9.72e-05	134	220	8	GO:0010906
GeneOntologyBiologicalProcess	protein localization to organelle	RGPD4 RGPD1 SRP72 KPNA6 IRS1 RYR2 PIK3R4 FSIP2 SQSTM1 HPS4 RGPD3 VPS13A MKLN1 PPP1R9B TMED2 KPNA1 RGPD5 RANBP2 RGPD8 NUP98 SIRT1 VPS13D OPTN AKAP11 LACRT RPA2	1.08e-04	1091	220	26	GO:0033365
GeneOntologyBiologicalProcess	regulation of gluconeogenesis	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 SIRT1	1.11e-04	71	220	6	GO:0006111
GeneOntologyBiologicalProcess	negative regulation of canonical NF-kappaB signal transduction	CASP8 AZI2 SIRT1 SNIP1 OPTN HDAC1	1.20e-04	72	220	6	GO:0043124
GeneOntologyBiologicalProcess	gluconeogenesis	RGPD4 RGPD1 RGPD3 GPD2 RANBP2 RGPD8 SIRT1	1.90e-04	111	220	7	GO:0006094
GeneOntologyBiologicalProcess	regulation of carbohydrate metabolic process	RGPD4 ACACB RGPD1 IRS1 NFKB1 RGPD3 RANBP2 RGPD8 SIRT1 PPP1R3A	1.96e-04	231	220	10	GO:0006109
GeneOntologyBiologicalProcess	hexose biosynthetic process	RGPD4 RGPD1 RGPD3 GPD2 RANBP2 RGPD8 SIRT1	2.36e-04	115	220	7	GO:0019319
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	PCDHB14 PCDHGA12 DCHS1 PCDH1 CDH5	2.50e-04	53	220	5	GO:0016339
GeneOntologyBiologicalProcess	peptidyl-proline modification	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.73e-04	54	220	5	GO:0018208
GeneOntologyBiologicalProcess	ossification involved in bone maturation	RYR1 FAT4 THBS3 DCHS1	2.78e-04	30	220	4	GO:0043931
GeneOntologyBiologicalProcess	glucose metabolic process	RGPD4 ACACB PDHA2 RGPD1 IRS1 RGPD3 GPD2 RANBP2 RGPD8 SIRT1	3.04e-04	244	220	10	GO:0006006
GeneOntologyBiologicalProcess	monosaccharide biosynthetic process	RGPD4 RGPD1 RGPD3 GPD2 RANBP2 RGPD8 SIRT1	3.22e-04	121	220	7	GO:0046364
GeneOntologyBiologicalProcess	carbohydrate biosynthetic process	RGPD4 RGPD1 IRS1 NFKB1 RGPD3 GPD2 RANBP2 RGPD8 SIRT1 PPP1R3A	3.35e-04	247	220	10	GO:0016051
GeneOntologyBiologicalProcess	protein localization to Golgi apparatus	VPS13A VPS13D OPTN LACRT	3.58e-04	32	220	4	GO:0034067
GeneOntologyBiologicalProcess	bone maturation	RYR1 FAT4 THBS3 DCHS1	4.04e-04	33	220	4	GO:0070977
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	2.95e-10	10	225	6	GO:0044614
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	7.54e-09	8	225	5	GO:1990723
GeneOntologyCellularComponent	nuclear pore nuclear basket	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	2.42e-08	18	225	6	GO:0044615
GeneOntologyCellularComponent	nuclear inclusion body	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	4.97e-08	20	225	6	GO:0042405
GeneOntologyCellularComponent	annulate lamellae	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.56e-07	14	225	5	GO:0005642
GeneOntologyCellularComponent	SUMO ligase complex	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.44e-06	21	225	5	GO:0106068
GeneOntologyCellularComponent	nuclear pore	RGPD4 RGPD1 RGPD3 KPNA1 RGPD5 RANBP2 RGPD8 NUP98	1.36e-05	101	225	8	GO:0005643
GeneOntologyCellularComponent	inclusion body	RGPD4 RGPD1 SQSTM1 RGPD3 RANBP2 RGPD8 NUP98	5.34e-05	90	225	7	GO:0016234
MousePheno	abnormal morula morphology	RGPD4 SPTB RGPD1 RGPD3 RANBP2 RGPD8	8.32e-07	26	182	6	MP:0012058
MousePheno	elevated level of mitotic sister chromatid exchange	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.38e-06	16	182	5	MP:0003701
MousePheno	abnormal spine curvature	BRINP3 DIS3L2 PABPC4 TUSC2 FOXN3 NR6A1 RYR1 NELL1 SQSTM1 FAT4 COL12A1 CASK ZNF106 DCHS1 SLX4	1.79e-05	318	182	15	MP:0004174
MousePheno	decreased tumor latency	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	3.87e-05	30	182	5	MP:0010308
MousePheno	failure of blastocyst formation	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	4.57e-05	31	182	5	MP:0012129
MousePheno	abnormal tumor latency	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	7.25e-05	34	182	5	MP:0010307
MousePheno	abnormal intracellular organelle morphology	RGPD4 KIAA0586 RGPD1 RYR1 RYR2 AP5Z1 RGPD3 VPS13A TALDO1 RANBP2 COL12A1 RGPD8 KAT6A SIRT1 MFN1 LIMK1 SLX4 VPS13B MMUT	9.30e-05	546	182	19	MP:0014239
MousePheno	aneuploidy	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 SIRT1	1.38e-04	61	182	6	MP:0004024
MousePheno	abnormal blastocyst formation	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.42e-04	39	182	5	MP:0012128
Domain	Cadherin	CDHR5 FREM2 FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 FREM3 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.24e-11	118	225	15	IPR002126
Domain	CA	CDHR5 FREM2 FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.10e-10	115	225	14	SM00112
Domain	Cadherin_CS	CDHR5 FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	6.71e-10	109	225	13	IPR020894
Domain	CADHERIN_1	CDHR5 FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.06e-09	113	225	13	PS00232
Domain	CADHERIN_2	CDHR5 FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.18e-09	114	225	13	PS50268
Domain	-	CDHR5 FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.18e-09	114	225	13	2.60.40.60
Domain	Cadherin-like	CDHR5 FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.47e-09	116	225	13	IPR015919
Domain	Ran_BP1	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8	2.49e-09	12	225	6	PF00638
Domain	RANBD1	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8	2.49e-09	12	225	6	PS50196
Domain	RanBD	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8	4.57e-09	13	225	6	SM00160
Domain	Ran_bind_dom	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8	4.57e-09	13	225	6	IPR000156
Domain	Cadherin	FAT1 FAT4 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 DCHS1 PCDH1 CDH5	1.18e-08	113	225	12	PF00028
Domain	Grip	RGPD4 RGPD1 RGPD3 RGPD5 RGPD8	1.06e-07	11	225	5	SM00755
Domain	GRIP	RGPD4 RGPD1 RGPD3 RGPD5 RGPD8	1.06e-07	11	225	5	PF01465
Domain	GRIP_dom	RGPD4 RGPD1 RGPD3 RGPD5 RGPD8	1.79e-07	12	225	5	IPR000237
Domain	GRIP	RGPD4 RGPD1 RGPD3 RGPD5 RGPD8	1.79e-07	12	225	5	PS50913
Domain	Rab_bind	RGPD4 RGPD1 RGPD3 RGPD8	6.98e-07	7	225	4	PF16704
Domain	GCC2_Rab_bind	RGPD4 RGPD1 RGPD3 RGPD8	6.98e-07	7	225	4	IPR032023
Domain	Chorein_N	VPS13A ATG2B VPS13D VPS13B	1.38e-06	8	225	4	PF12624
Domain	VPS13_N	VPS13A ATG2B VPS13D VPS13B	1.38e-06	8	225	4	IPR026854
Domain	Growth_fac_rcpt_	BRINP3 NELL1 FAT1 HMCN2 C8A FAT4 FRAS1 COMP THBS3 CELSR2 TNXB	3.06e-06	156	225	11	IPR009030
Domain	-	RGPD4 RGPD1 RGPD3 RGPD8	4.07e-06	10	225	4	1.10.220.60
Domain	Laminin_G	NELL1 FAT1 FAT4 COL12A1 THBS3 CELSR3 CELSR2	5.98e-06	58	225	7	IPR001791
Domain	SHR-BD	VPS13A VPS13D VPS13B	6.84e-06	4	225	3	IPR009543
Domain	VPS13_C	VPS13A VPS13D VPS13B	6.84e-06	4	225	3	PF16909
Domain	VPS13_C	VPS13A VPS13D VPS13B	6.84e-06	4	225	3	IPR031645
Domain	SHR-BD	VPS13A VPS13D VPS13B	6.84e-06	4	225	3	PF06650
Domain	ConA-like_dom	RYR1 RYR2 NELL1 FAT1 TRIM36 FAT4 COL12A1 COMP THBS3 CELSR3 CELSR2 RNF39	1.46e-05	219	225	12	IPR013320
Domain	Autophagy-rel_C	VPS13A ATG2B VPS13B	1.69e-05	5	225	3	IPR015412
Domain	ATG_C	VPS13A ATG2B VPS13B	1.69e-05	5	225	3	PF09333
Domain	EGF_CA	NELL1 FAT1 HMCN2 FAT4 COMP CRTAC1 THBS3 CELSR3 CELSR2	1.71e-05	122	225	9	SM00179
Domain	-	NELL1 FAT1 FAT4 COL12A1 COMP THBS3 CELSR3 CELSR2	1.94e-05	95	225	8	2.60.120.200
Domain	EGF-like_Ca-bd_dom	NELL1 FAT1 HMCN2 FAT4 COMP CRTAC1 THBS3 CELSR3 CELSR2	1.95e-05	124	225	9	IPR001881
Domain	EGF-like_dom	NELL1 FAT1 HMCN2 C8A FAT4 FRAS1 COMP CRTAC1 THBS3 CELSR3 CELSR2 TNXB	5.16e-05	249	225	12	IPR000742
Domain	EGF_CA	NELL1 FAT1 HMCN2 FAT4 COMP CRTAC1 THBS3	8.04e-05	86	225	7	PF07645
Domain	Calx_beta	FREM2 FRAS1 FREM3	9.24e-05	8	225	3	SM00237
Domain	Laminin_G_2	NELL1 FAT1 FAT4 CELSR3 CELSR2	1.13e-04	40	225	5	PF02210
Domain	Cadherin_2	PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 PCDHGA12 PCDH1	1.31e-04	65	225	6	PF08266
Domain	Cadherin_N	PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 PCDHGA12 PCDH1	1.31e-04	65	225	6	IPR013164
Domain	EGF_3	NELL1 FAT1 HMCN2 C8A FAT4 COMP CRTAC1 THBS3 CELSR3 CELSR2 TNXB	1.37e-04	235	225	11	PS50026
Domain	Calx_beta	FREM2 FRAS1 FREM3	1.37e-04	9	225	3	IPR003644
Domain	Calx-beta	FREM2 FRAS1 FREM3	1.37e-04	9	225	3	PF03160
Domain	EGF_Ca-bd_CS	NELL1 FAT1 HMCN2 FAT4 COMP CRTAC1 THBS3	1.72e-04	97	225	7	IPR018097
Domain	LamG	NELL1 FAT1 FAT4 CELSR3 CELSR2	1.80e-04	44	225	5	SM00282
Domain	EGF_CA	NELL1 FAT1 HMCN2 FAT4 COMP CRTAC1 THBS3	1.95e-04	99	225	7	PS01187
Domain	PH_dom-like	RGPD4 NET1 RGPD1 IRS1 RGPD3 PLEKHA7 TNS3 ARAP1 RGPD5 RANBP2 RGPD8 BBS5 ARHGEF25 RGS12 SBF2	2.15e-04	426	225	15	IPR011993
Domain	EGF_1	NELL1 FAT1 HMCN2 C8A FAT4 COMP CRTAC1 THBS3 CELSR3 CELSR2 TNXB	2.78e-04	255	225	11	PS00022
Domain	K_chnl_volt-dep_Kv	KCNV2 KCNA1 KCNA10 KCND1	2.89e-04	27	225	4	IPR003968
Domain	-	RGPD4 NET1 RGPD1 IRS1 RGPD3 PLEKHA7 TNS3 ARAP1 RANBP2 RGPD8 BBS5 ARHGEF25 RGS12 SBF2	2.94e-04	391	225	14	2.30.29.30
Domain	EGF-like_CS	NELL1 FAT1 HMCN2 C8A FAT4 COMP CRTAC1 THBS3 CELSR3 CELSR2 TNXB	3.39e-04	261	225	11	IPR013032
Domain	EGF_2	NELL1 FAT1 HMCN2 C8A FAT4 COMP CRTAC1 THBS3 CELSR3 CELSR2 TNXB	3.86e-04	265	225	11	PS01186
Domain	COMP	COMP THBS3	4.30e-04	3	225	2	PF11598
Domain	Ryanodine_rcpt	RYR1 RYR2	4.30e-04	3	225	2	IPR003032
Domain	Thbs/COMP_coiled-coil	COMP THBS3	4.30e-04	3	225	2	IPR024665
Domain	VPS13	VPS13A VPS13D	4.30e-04	3	225	2	IPR026847
Domain	Ryanrecept_TM4-6	RYR1 RYR2	4.30e-04	3	225	2	IPR009460
Domain	VPS13_mid_rpt	VPS13A VPS13D	4.30e-04	3	225	2	PF16910
Domain	VPS13	VPS13A VPS13D	4.30e-04	3	225	2	PF16908
Domain	RyR	RYR1 RYR2	4.30e-04	3	225	2	PF02026
Domain	VPS13_N2	VPS13A VPS13D	4.30e-04	3	225	2	IPR031646
Domain	VPS13_mid_rpt	VPS13A VPS13D	4.30e-04	3	225	2	IPR031642
Domain	RR_TM4-6	RYR1 RYR2	4.30e-04	3	225	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	4.30e-04	3	225	2	IPR013333
Domain	TPR-contain_dom	RGPD4 RGPD1 SRP72 RGPD3 VPS13A RGPD5 RANBP2 RGPD8	4.76e-04	150	225	8	IPR013026
Domain	EGF	BRINP3 NELL1 FAT1 FAT4 FRAS1 COMP THBS3 CELSR3 CELSR2 TNXB	5.83e-04	235	225	10	SM00181
Domain	VG_K_chnl	KCNV2 KCNA1 KCNA10 KCND1	6.38e-04	33	225	4	IPR028325
Domain	GRAM	TBC1D9B GRAMD1B SBF2	8.60e-04	16	225	3	SM00568
Domain	TPR_REGION	RGPD4 RGPD1 SRP72 RGPD3 VPS13A RGPD5 RANBP2 RGPD8	8.91e-04	165	225	8	PS50293
Domain	TPR	RGPD4 RGPD1 SRP72 RGPD3 VPS13A RGPD5 RANBP2 RGPD8	8.91e-04	165	225	8	PS50005
Domain	Cadherin_tail	PCDHGC5 PCDHGA4 PCDHA10 PCDHGA12	9.92e-04	37	225	4	PF15974
Domain	Cadherin_CBD	PCDHGC5 PCDHGA4 PCDHA10 PCDHGA12	9.92e-04	37	225	4	IPR031904
Domain	LAM_G_DOMAIN	FAT1 FAT4 CELSR3 CELSR2	1.10e-03	38	225	4	PS50025
Domain	ASX_HYDROXYL	NELL1 FAT1 HMCN2 FAT4 CELSR3 CELSR2	1.33e-03	100	225	6	PS00010
Domain	TSP_3	COMP THBS3	1.41e-03	5	225	2	PF02412
Domain	TSP3	COMP THBS3	1.41e-03	5	225	2	PS51234
Domain	TSP_CTER	COMP THBS3	1.41e-03	5	225	2	PS51236
Domain	Thrombospondin_3_rpt	COMP THBS3	1.41e-03	5	225	2	IPR017897
Domain	TSP_type-3_rpt	COMP THBS3	1.41e-03	5	225	2	IPR028974
Domain	CPSASE_1	ACACB CAD	1.41e-03	5	225	2	PS00866
Domain	-	COMP THBS3	1.41e-03	5	225	2	4.10.1080.10
Domain	Thrombospondin_C	COMP THBS3	1.41e-03	5	225	2	IPR008859
Domain	TSP_C	COMP THBS3	1.41e-03	5	225	2	PF05735
Domain	Thrombospondin_3-like_rpt	COMP THBS3	1.41e-03	5	225	2	IPR003367
Domain	Cadherin_C	PCDHGC5 PCDHGA4 PCDHB14 PCDHGA12	1.60e-03	42	225	4	IPR032455
Domain	Cadherin_C_2	PCDHGC5 PCDHGA4 PCDHB14 PCDHGA12	1.60e-03	42	225	4	PF16492
Domain	PDZ	RHPN1 PPP1R9B RGS12 CASK LIMK1 TJP1 PATJ	1.62e-03	141	225	7	PF00595
Domain	RasGEFN	RASGRP3 RASGEF1A KNDC1	1.69e-03	20	225	3	SM00229
Domain	EGF-type_Asp/Asn_hydroxyl_site	NELL1 FAT1 HMCN2 FAT4 CELSR3 CELSR2	1.79e-03	106	225	6	IPR000152
Domain	RasGEF_N	RASGRP3 RASGEF1A KNDC1	1.95e-03	21	225	3	PF00618
Domain	RIH_assoc-dom	RYR1 RYR2	2.10e-03	6	225	2	IPR013662
Domain	COLD_SHOCK	CSDC2 CSDE1	2.10e-03	6	225	2	PS00352
Domain	Cold-shock_CS	CSDC2 CSDE1	2.10e-03	6	225	2	IPR019844
Domain	Ins145_P3_rec	RYR1 RYR2	2.10e-03	6	225	2	PF08709
Domain	RIH_assoc	RYR1 RYR2	2.10e-03	6	225	2	PF08454
Domain	RIH_dom	RYR1 RYR2	2.10e-03	6	225	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2	2.10e-03	6	225	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2	2.10e-03	6	225	2	IPR015925
Domain	CPSASE_2	ACACB CAD	2.10e-03	6	225	2	PS00867
Domain	-	RYR1 RYR2	2.10e-03	6	225	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR2	2.10e-03	6	225	2	PF01365
Pathway	BIOCARTA_RANBP2_PATHWAY	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.19e-06	18	156	5	MM1549
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98 SIRT1 RPA2	1.37e-06	73	156	8	MM14948
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	4.69e-06	40	156	6	MM14945
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	5.45e-06	41	156	6	MM15200
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	6.30e-06	42	156	6	MM15039
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98 HDAC1	7.22e-06	65	156	7	MM15147
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	7.25e-06	43	156	6	MM14609
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98 SIRT1 RPA2	7.96e-06	92	156	8	MM14951
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	1.23e-05	47	156	6	MM14939
Pathway	REACTOME_GENE_SILENCING_BY_RNA	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	1.57e-05	49	156	6	MM14837
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	1.77e-05	50	156	6	MM14610
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	1.99e-05	51	156	6	MM15151
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	3.09e-05	55	156	6	MM14917
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	4.20e-05	58	156	6	MM15149
Pathway	REACTOME_SNRNP_ASSEMBLY	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	4.20e-05	58	156	6	MM14736
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNV2 KCNA1 KCNA10 KCND1 KCNAB3	8.46e-05	41	156	5	MM14546
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNV2 KCNA1 KCNA10 KCND1 KCNAB3	1.07e-04	43	156	5	M1056
Pathway	REACTOME_GLUCOSE_METABOLISM	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	2.92e-04	82	156	6	MM15394
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	3.33e-04	84	156	6	MM14929
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	3.78e-04	86	156	6	MM15413
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RGPD4 PCYT1A DCAF8 PABPC4 RGPD1 KPNA6 POGZ CSDE1 PHKB SERPINA1 SQSTM1 RGPD3 TUBGCP3 ALDH18A1 TMED2 ARAP1 KPNA1 RGPD5 RANBP2 RGPD8 NUP98 SHLD1 FAAP100 SIRT1 ACTR1A NBAS ZNF106 TJP1 EIF3D RPA2 SLX4 VPS13B	5.34e-12	1155	226	32	20360068
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TBC1D9B UBE4B PIEZO1 IRS1 RYR1 GGT7 RHPN1 FAT1 PDIA5 CPVL ARAP1 RAD51 ATMIN PLXNA3 FRAS1 KAT6A MYOM3 FRYL FAAP100 SBNO2 ACTR1A MYOF AATK CELSR3 CELSR2 GAREM2 SND1 SBF2 DEPDC5 ZNF839	4.30e-11	1105	226	30	35748872
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	1.16e-10	13	226	6	31427429
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	9037092
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	21205196
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	24403063
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	22821000
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD4 RGPD1 RGPD3 RGPD5 RGPD8	2.30e-10	7	226	5	15710750
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	38657106
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	26632511
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	23818861
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.30e-10	7	226	5	20682751
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	6.11e-10	8	226	5	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	6.11e-10	8	226	5	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	6.11e-10	8	226	5	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	6.11e-10	8	226	5	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	6.11e-10	8	226	5	28745977
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.37e-09	9	226	5	28100513
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.37e-09	9	226	5	17887960
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.37e-09	9	226	5	9733766
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.37e-09	9	226	5	18394993
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.37e-09	9	226	5	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.37e-09	9	226	5	10601307
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	1.37e-09	9	226	5	28877029
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.72e-09	10	226	5	16332688
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.72e-09	10	226	5	27160050
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.72e-09	10	226	5	8857542
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.72e-09	10	226	5	21859863
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	4.96e-09	11	226	5	17069463
Pubmed	T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	4.96e-09	11	226	5	34110283
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	4.96e-09	11	226	5	35771867
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SMG1 ATP6V1A TBC1D9B DCAF8 PABPC4 SRP72 SSR4 PGM3 CSDE1 GRAMD1B ADSS2 COX5A SQSTM1 NFKB1 UFD1 ALDH18A1 TMED2 CPVL GPD2 RANBP2 CAD JADE2 ACTR1A NBAS MYOF OPTN SND1 EIF3D STX16 RPA2	2.03e-08	1440	226	30	30833792
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GPRASP1 PCYT1A DCAF8 UBE4B SPTB PEG3 ZBTB43 KPNA6 POGZ PIK3R4 CSDE1 NELL1 CLK1 HPS4 SERGEF USP32 MKLN1 JAKMIP1 KPNA1 DMXL2 JADE2 CRTAC1 CASK LIMK1 CELSR3 TJP1 EIF3D SLX4	2.47e-08	1285	226	28	35914814
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	3.16e-08	15	226	5	14697343
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12 PCDH1	5.45e-08	80	226	8	10716726
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	RGPD4 RGPD1 RGPD3 RANBP2 CAD RGPD8 SIRT1 SBNO2 EIF3D HDAC1	7.02e-08	153	226	10	26365490
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD4 SMG1 PHACTR2 GLS2 ACACB PABPC4 EML6 RGPD1 SRP72 RYR2 FAM161A RGPD3 VPS13A PPP1R9B DLEC1 JAKMIP1 BSN RGPD5 PLXNA3 RANBP2 RGPD8 PCDHGC5 PCDHGA4 NUP98 SND1 PCDHGA12 TJP1 NGLY1 HDAC1	7.58e-08	1442	226	29	35575683
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	KPNA6 SSR4 PHKB NFKB1 VPS13A ALDH18A1 NHS HELZ PPP1R9B TRIM36 PLEKHA7 CPVL TNS3 KPNA1 GPD2 RANBP2 CAD NUP98 CASK TJP1 SBF2 SETD7 STX16 RPA2	1.09e-07	1049	226	24	27880917
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RGPD4 GPRASP1 ATP6V1A ACACB RGPD1 RYR2 GGT7 CSDE1 GRAMD1B KCNA1 SQSTM1 RGPD3 MKLN1 HELZ PPP1R9B BSN AMPD2 RANBP2 DMXL2 CAD RGPD8 ATG2B CELSR2 TJP1 KNDC1	1.28e-07	1139	226	25	36417873
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8 NUP98	1.63e-07	38	226	6	12791264
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RGPD4 ACACB RGPD1 SRP72 RGPD3 UFD1 TUBGCP3 HELZ RAD51 RANBP2 CAD RGPD8 SUGP1 HDAC1	1.68e-07	370	226	14	22922362
Pubmed	Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.	ITGA9 FAT4 DCHS1 CDH5	2.13e-07	9	226	4	28705793
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PHACTR2 NET1 RASSF2 IRS1 PIK3R4 FSIP2 SQSTM1 NHS HELZ PLEKHA7 TNS3 AMPD2 FRYL RGS12 ZNF106 LIMK1 VPS13D OPTN TJP1 AKAP11 PATJ	2.53e-07	861	226	21	36931259
Pubmed	Terminal differentiation of cortical neurons rapidly remodels RanGAP-mediated nuclear transport system.	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	2.67e-07	22	226	5	27717094
Pubmed	Expression of Fraser syndrome genes in normal and polycystic murine kidneys.	FREM2 FRAS1 FREM3	2.71e-07	3	226	3	21993971
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR3 CELSR2 PCDHGA12	4.59e-07	72	226	7	10380929
Pubmed	Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation.	FAT1 FAT4 TJP1 DCHS1	5.53e-07	11	226	4	26114487
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	CDHR5 PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 PCDHGA12 PCDH1	5.54e-07	74	226	7	10817752
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NET1 PIEZO1 CLK4 PABPC4 NBPF26 SRP72 CSDE1 COX5A SQSTM1 RGPD3 ALDH18A1 HELZ TMED2 PLEKHA7 KPNA1 RANBP2 CAD ABCB6 CASK SNIP1 ACTR1A MRM3 MYOF SND1 EIF3D PATJ STX16 HDAC1	5.57e-07	1497	226	28	31527615
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	UBR1 ATP6V1A ABCF3 PDHA2 PABPC4 SRP72 IRS1 SSR4 ADSS2 SQSTM1 ALDH18A1 NHS TALDO1 TNS3 RAD51 RANBP2 CAD NUP98 ACTR1A MYOF TJP1 EIF3D PATJ RPA2 HDAC1	6.82e-07	1247	226	25	27684187
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 CELSR2 PCDHGA12 PCDH1	7.29e-07	77	226	7	10835267
Pubmed	Analysis of the human VPS13 gene family.	VPS13A VPS13D VPS13B	1.08e-06	4	226	3	15498460
Pubmed	Differential localization profile of Fras1/Frem proteins in epithelial basement membranes of newborn and adult mice.	FREM2 FRAS1 FREM3	1.08e-06	4	226	3	18563433
Pubmed	Segmental and restricted localization pattern of Fras1 in the developing meningeal basement membrane in mouse.	FREM2 FRAS1 FREM3	1.08e-06	4	226	3	24101214
Pubmed	Identification of a novel Ran binding protein 2 related gene (RANBP2L1) and detection of a gene cluster on human chromosome 2q11-q12.	RGPD5 RANBP2 RGPD8	1.08e-06	4	226	3	9480752
Pubmed	Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.	SMG1 GPRASP1 ZBTB43 AP5Z1 BSN ATMIN	1.12e-06	52	226	6	9455477
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	CDHR5 FAT1 NRK USP32 PLEKHA7 FAM135A TNS3 COL17A1 NECTIN3 RGS12 CASK OPTN CELSR2 PATJ PCDH1 VPS13B	1.17e-06	569	226	16	30639242
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	ATP6V1A DCAF8 SRP72 KPNA6 SSR4 CSDE1 SQSTM1 ALDH18A1 CPVL KPNA1 RGPD5 RANBP2 CAD NUP98 SIRT1 PATJ	1.22e-06	571	226	16	37167062
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	PABPC4 SIDT1 CSMD3 RGPD3 L3HYPDH FAT4 FRAS1 CAD RGPD8 PCDHGC5 ATG2B NUP98 MFN1 ACTR1A CELSR3	1.58e-06	513	226	15	25798074
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	ATP6V1A KPNA6 SQSTM1 ALDH18A1 PPP1R9B KPNA1 RANBP2 CAD NUP98 CASK MRM3 MYOF SND1 TJP1 EIF3D RPA2 HDAC1	1.77e-06	660	226	17	32780723
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	PHACTR2 RYR1 CSDC2 CSDE1 HIBCH VPS13A PCDHA10 GSX2 CELSR3 CELSR2 EIF3D HDAC1	1.91e-06	329	226	12	17474147
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	RGPD4 PCYT1A RGPD1 RGPD3 ALDH18A1 RANBP2 RGPD8 NUP98 MYOF TJP1	2.54e-06	226	226	10	37839992
Pubmed	Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly.	FAT1 FAT4 TJP1	2.68e-06	5	226	3	30862798
Pubmed	Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.	FREM2 FRAS1 FREM3	2.68e-06	5	226	3	17596926
Pubmed	Multiple cadherins are expressed in human fibroblasts.	FAT1 PCDHGA12 DCHS1	2.68e-06	5	226	3	9199196
Pubmed	Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development.	FREM2 FRAS1 FREM3	2.68e-06	5	226	3	17251066
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PCYT1A ATP6V1A ABCF3 DCAF8 UBE4B PABPC4 SRP72 KPNA6 CSDE1 ADSS2 SQSTM1 UFD1 TALDO1 TNS3 KPNA1 RAD51 AMPD2 NUP98 FRYL SIRT1 ACTR1A OPTN SND1 EIF3D RPA2 HDAC1	3.34e-06	1455	226	26	22863883
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	RGPD4 SMG1 SPTB PABPC4 CSDE1 SQSTM1 RGPD3 RGPD5 RANBP2 CAD RGPD8 ACTR1A TJP1 EIF3D RPA2 HDAC1	3.96e-06	626	226	16	33644029
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	GPRASP1 DCAF8 NET1 KPNA6 FOXN3 SSR4 RYR1 PIK3R4 CSDE1 SERPINA1 FAT1 HIBCH TUBGCP3 HELZ TMED2 COL12A1 KAT6A BBS5 SBNO2 ZNF419 SNIP1 XPNPEP3 DEPDC5 TNXB	4.33e-06	1293	226	24	15342556
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATP6V1A DCAF8 UBE4B SPTB FOXN3 CSDE1 PHKB MKLN1 PDIA5 PPP1R9B ARAP1 KPNA1 ATMIN JADE2 KAT6A FRYL SBNO2 CASK TJP1 SBF2 XPNPEP3 KNDC1 PATJ ZNF839 PCDH1 VPS13B	5.05e-06	1489	226	26	28611215
Pubmed	Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex.	FAT4 TJP1 DCHS1	5.34e-06	6	226	3	19506035
Pubmed	Frem3, a member of the 12 CSPG repeats-containing extracellular matrix protein family, is a basement membrane protein with tissue distribution patterns distinct from those of Fras1, Frem2, and QBRICK/Frem1.	FREM2 FRAS1 FREM3	5.34e-06	6	226	3	17462874
Pubmed	IPO3-mediated Nonclassical Nuclear Import of NF-κB Essential Modulator (NEMO) Drives DNA Damage-dependent NF-κB Activation.	KPNA6 NFKB1 KPNA1	5.34e-06	6	226	3	26060253
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SMG1 SPTB PEG3 SRP72 SSR4 RYR1 CLK1 TUBGCP3 MKLN1 RANBP2 DMXL2 COL12A1 MYOM3 OPTN	5.41e-06	497	226	14	23414517
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP32 ALDH18A1 DMXL2 FRYL ACTR1A TJP1 DEPDC5 RPA2	5.77e-06	147	226	8	29576527
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ATP6V1A PABPC4 KIAA0586 SRP72 KPNA6 POGZ SSR4 PIK3R4 ADSS2 SQSTM1 ALDH18A1 BSN PLEKHA7 TALDO1 GPD2 RANBP2 CAD NUP98 ACTR1A MRM3 SND1 EIF3D STX16 RPA2 HDAC1	7.17e-06	1425	226	25	30948266
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	SMG1 RASSF2 CLK4 PIK3R4 GRAMD1B PHKB CLK1 NRK PDIA5 TNS3 AZI2 ACTR1A MYOF LIMK1 OPTN SND1 AKAP11 EIF3D HDAC1	9.04e-06	910	226	19	36736316
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT1 FAT4 DCHS1	9.30e-06	7	226	3	16059920
Pubmed	Differential expression of individual gamma-protocadherins during mouse brain development.	PCDHGC5 PCDHGA4 PCDHGA12	9.30e-06	7	226	3	15964765
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	UBR1 ABCF3 CSDE1 ADSS2 HIBCH NFKB1 ALDH18A1 TMED2 TALDO1 TNS3 GPD2 AMPD2 RANBP2 NUP98 FRYL ACTR1A MYOF OPTN SND1 TJP1 EIF3D NGLY1 MMUT HDAC1	1.09e-05	1367	226	24	32687490
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	PABPC4 CSDE1 HIBCH UFD1 CPVL TALDO1 KPNA1 RANBP2 CAD NUP98 ACTR1A XPNPEP3 EIF3D MMUT	1.21e-05	534	226	14	35032548
Pubmed	Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.	DCAF8 PDHA2 ZBTB43 KPNA6 PHKB COX5A HELZ TMED2 CPVL KPNA1 RAD51 ATG2B SIRT1 ACTR1A MRM3 SND1 LACRT NGLY1 STX16	1.24e-05	931	226	19	27432908
Pubmed	Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays.	GLS2 CASK TJP1 PATJ	1.40e-05	23	226	4	16637659
Pubmed	Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation.	PIEZO1 ITGA9 CDH5	1.48e-05	8	226	3	30482854
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	SRP72 COX5A HIBCH SQSTM1 VPS13A CPVL PGBD5 GPD2 CAD RGPD8 ATG2B NUP98 SIRT1 MFN1 CASK SNIP1 NBAS MRM3 VPS13D SND1 TRABD AKAP11 RPA2 VPS13B MMUT	1.63e-05	1496	226	25	32877691
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD4 GPRASP1 RGPD1 KCNA1 RGPD3 PPP1R9B JAKMIP1 BSN KPNA1 AMPD2 RANBP2 DMXL2 CAD RGPD8 CASK ACTR1A CELSR2 TJP1 DCHS1	1.98e-05	963	226	19	28671696
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	PCYT1A ATP6V1A PGM3 SQSTM1 AP5Z1 TUBGCP3 ALDH18A1 CPVL KPNA1 GPD2 CASK SUGP1 SETD7 HDAC1	2.05e-05	560	226	14	35241646
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	RGPD4 PEG3 RGPD1 RGPD3 RANBP2 RGPD8	2.15e-05	86	226	6	37253089
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	RGPD4 ATP6V1A PABPC4 RGPD1 KPNA6 SSR4 PGM3 PIK3R4 CSDE1 SQSTM1 RGPD3 UFD1 ALDH18A1 KPNA1 RGPD5 RANBP2 CAD RGPD8 ACTR1A SND1 RPA2 HDAC1	2.71e-05	1257	226	22	37317656
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	ABCF3 PABPC4 SRP72 CSDE1 UFD1 ALDH18A1 PDIA5 BSN FRAS1 MFN1 PPP1R3A MRM3 SND1 EIF3D HDAC1	2.77e-05	653	226	15	33742100
Interaction	C2CD4B interactions	PHKB FREM2 FAT1 ALDH18A1 FAT4 FRAS1 CELSR2 PATJ	2.67e-08	44	225	8	int:C2CD4B
Interaction	DCANP1 interactions	FREM2 FAT1 FAT4 CELSR3 CELSR2 DCHS1	4.35e-08	19	225	6	int:DCANP1
Interaction	NXPH2 interactions	UBR1 FREM2 FAT1 FAT4 FRAS1 CELSR2 PCDH1	6.57e-08	33	225	7	int:NXPH2
Interaction	RGPD4 interactions	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8	1.16e-07	22	225	6	int:RGPD4
Interaction	XAGE1A interactions	FREM2 FAT1 FAT4 FRAS1 CELSR3 CELSR2 DCHS1	3.21e-07	41	225	7	int:XAGE1A
Interaction	RGPD2 interactions	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8	4.41e-07	27	225	6	int:RGPD2
Interaction	RGPD3 interactions	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8 SLX4	8.47e-07	47	225	7	int:RGPD3
Interaction	RGPD1 interactions	RGPD4 RGPD1 RGPD3 RGPD5 RANBP2 RGPD8 NUP98	1.14e-06	49	225	7	int:RGPD1
Interaction	TOP3B interactions	TBC1D9B UBE4B PIEZO1 SPTB SRP72 IRS1 RYR1 GGT7 CSDE1 RHPN1 FAT1 PDIA5 HELZ PPP1R9B CPVL ARAP1 RAD51 ATMIN PLXNA3 FRAS1 CAD KAT6A MYOM3 FRYL FAAP100 SBNO2 ACTR1A MYOF AATK CELSR3 CELSR2 GAREM2 SND1 SBF2 DEPDC5 ZNF839 RPA2	2.62e-06	1470	225	37	int:TOP3B
Interaction	PSG8 interactions	FREM2 FAT1 FAT4 FRAS1 CELSR3 CELSR2	5.88e-06	41	225	6	int:PSG8
Interaction	IFNE interactions	ACACB FAT1 FAT4 FRAS1 PCDH1	1.10e-05	27	225	5	int:IFNE
Interaction	PAK6 interactions	DCAF8 ACACB PPP1R9B CPVL CAD LIMK1 TNXB	1.72e-05	73	225	7	int:PAK6
Interaction	PCDHGB1 interactions	FREM2 GPD2 FAT4 CELSR3 CELSR2 PCDHGA12 DCHS1	2.44e-05	77	225	7	int:PCDHGB1
Interaction	RAN interactions	RGPD4 DCAF8 PABPC4 RGPD1 KPNA6 RGPD3 PPP1R9B KPNA1 RGPD5 RANBP2 RGPD8 NUP98 SNIP1 OPTN RPA2 SLX4 HDAC1	2.63e-05	475	225	17	int:RAN
Interaction	NUP50 interactions	PCYT1A KPNA6 HELZ KPNA1 RANBP2 RGPD8 NUP98 SIRT1 PPP1R3A OPTN SUGP1 RPA2 SLX4 HDAC1	3.15e-05	341	225	14	int:NUP50
Interaction	DKKL1 interactions	TBC1D9B FREM2 FAT1 FAT4 FRAS1 CELSR3 CELSR2 PCDH1	3.51e-05	111	225	8	int:DKKL1
Interaction	NPIPB6 interactions	RGPD1 RGPD5 RANBP2 RGPD8	4.09e-05	18	225	4	int:NPIPB6
Interaction	RANBP2 interactions	RGPD4 RGPD1 DNAAF3 RGPD3 KPNA1 RGPD5 RANBP2 COL17A1 RGPD8 NUP98 SUGP1 RPA2 SLX4 HDAC1	5.84e-05	361	225	14	int:RANBP2
Interaction	SPSB4 interactions	UBR1 PIK3R4 FAT1 FAT4 CELSR3 CELSR2 DCHS1 PCDH1	7.73e-05	124	225	8	int:SPSB4
Interaction	NUP210P1 interactions	VPS13A FAT4 CELSR3 CELSR2 DCHS1	1.01e-04	42	225	5	int:NUP210P1
Interaction	LOC254896 interactions	FREM2 FAT1 FAT4 CELSR2 DCHS1	1.13e-04	43	225	5	int:LOC254896
Interaction	GSK3B interactions	UBR1 ACACB CLK4 KIAA0586 RGPD1 SRP72 IRS1 CSDE1 SQSTM1 NFKB1 NHS TNS3 GPD2 CAD ATG2B CARTPT MYOF VPS13D SND1 TJP1 AKAP11 RPA2 SLX4	1.15e-04	868	225	23	int:GSK3B
GeneFamily	Cadherin related	CDHR5 FAT1 FAT4 DCHS1	9.44e-06	17	148	4	24
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD4 RGPD1 SRP72 RGPD3 RGPD5 RANBP2 RGPD8	4.48e-05	115	148	7	769
GeneFamily	Clustered protocadherins	PCDHGC5 PCDHGA4 PCDHB14 PCDHA10 PCDHGA12	1.78e-04	64	148	5	20
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	1.99e-04	3	148	2	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	1.99e-04	3	148	2	1189
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	1.99e-04	3	148	2	287
GeneFamily	PDZ domain containing	RHPN1 PPP1R9B RGS12 CASK LIMK1 TJP1 PATJ	2.57e-04	152	148	7	1220
GeneFamily	Potassium voltage-gated channels	KCNV2 KCNA1 KCNA10 KCND1	3.13e-04	40	148	4	274
GeneFamily	CDC like kinases	CLK4 CLK1	3.95e-04	4	148	2	480
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	RYR1 CSRNP3 PPP1R9B PPP1R3A AATK AKAP11	3.78e-03	181	148	6	694
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	RGPD4 SMG1 GPRASP1 PHACTR2 DIS3L2 RGPD1 GRAMD1B PHKB CLK1 RGPD3 MKLN1 RGPD5 RANBP2 RGPD8 AZI2 SBNO2 PATJ	8.84e-07	474	226	17	M40991
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	8.89e-06	33	226	5	MM477
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	GPRASP1 PHACTR2 PEG3 CDHR5 IRS1 RANBP2 FAT4 AZI2 FAAP100 SIRT1 MYOF SUGP1 DCHS1 PATJ ZNF839 MMUT	9.20e-06	506	226	16	M253
Coexpression	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	KCNV2 SPTB SERPINA1 FCGR3A NFKB1 DLEC1 TALDO1 GPD2 SBNO2 MYOF	1.00e-05	200	226	10	M5228
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	IRS1 POGZ PIK3R4 FAT1 NFKB1 TUBGCP3 VPS13A HELZ KAT6A CASP8 FRYL VPS13B	1.27e-05	300	226	12	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	IRS1 FOXN3 PIK3R4 FAT1 NFKB1 TUBGCP3 VPS13A MKLN1 HELZ RANBP2 DMXL2 KAT6A NUP98 CASP8 FRYL NECTIN3 CASK NBAS MYOF AKAP11 VPS13B	1.83e-05	856	226	21	M4500
Coexpression	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN	ATP6V1A PHACTR2 DIS3L2 UBE4B FOXN3 HPS4 ATMIN DEPDC5 VPS13B	2.93e-05	181	226	9	M8662
Coexpression	TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING	RGPD4 RGPD1 RGPD3 RANBP2 RGPD8	3.36e-05	43	226	5	MM3857
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST	RASSF2 NRK PDIA5 COL12A1 THBS3 TNXB	3.45e-05	71	226	6	M45664
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	IRS1 FAT1 NFKB1 TUBGCP3 KAT6A CASP8 FRYL VPS13B	3.90e-05	145	226	8	M1810
Coexpression	GSE3982_BCELL_VS_TH2_UP	SIDT1 PHKB RASGRP3 KPNA1 JADE2 C1orf115 KDM7A RNF39 ZNF839	5.66e-05	197	226	9	M5554
Coexpression	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	SMG1 GPRASP1 ACACB KPNA6 RASGRP3 HPS4 NFKB1 ALDH18A1 JADE2	5.89e-05	198	226	9	M8624
Coexpression	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP	CDHR5 KCNA10 RAD51 GPD2 PLXNA3 FAT4 CRTAC1 FAAP100 RNF39	5.89e-05	198	226	9	M5011
Coexpression	MURARO_PANCREAS_BETA_CELL	GPRASP1 ATP6V1A PHACTR2 TBC1D9B PEG3 EML6 FOXN3 CSDE1 SQSTM1 HPS4 FAM135A AMPD2 RANBP2 DMXL2 AZI2 NECTIN3 ZNF106 AKAP11 KDM7A SETD7 RPA2	7.71e-05	946	226	21	M39169
Coexpression	DOUGLAS_BMI1_TARGETS_DN	PCYT1A ATP6V1A UBE4B KPNA6 PHKB CSRNP3 SQSTM1 ARAP1 CASP8 OPTN NGLY1	9.63e-05	314	226	11	M14279
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ILDR2 BRINP3 RYR2 NRK FAT4 COL12A1 COMP AOX1 PCDHA10 KCNT2 KCNAB3 TNXB	1.62e-10	181	226	12	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	severe_COVID-19-Non-classical_Monocyte\|severe_COVID-19 / disease group, cell group and cell class (v2)	PIK3AP1 SERPINA1 FCGR3A CPVL ARAP1 AMPD2 RGS12 MYOF FIBCD1 KNDC1	6.78e-08	196	226	10	34c1c74cad5e23196e86cfd6f19c836fe57b2264
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIEZO1 RNF112 ITGA9 DNAAF3 KCND1 RASGRP3 CRTAC1 CDH5 TNXB	3.20e-07	177	226	9	66ffa279147961080c104242a08b176e301d80e3
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIEZO1 RNF112 ITGA9 DNAAF3 KCND1 RASGRP3 CRTAC1 CDH5 TNXB	3.20e-07	177	226	9	227d4f423b00be2e0c5797e2c5275d342e69a0f4
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIEZO1 RNF112 ITGA9 DNAAF3 KCND1 RASGRP3 CRTAC1 CDH5 TNXB	3.20e-07	177	226	9	0cbf54608d2ba0a0500af142f2029fe5e118c3c2
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1A NET1 PEG3 ITGA9 CSDE1 PDIA5 TNS3 JADE2 KAT6A	6.33e-07	192	226	9	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 KCNV2 RYR2 CPVL FRAS1 COL12A1 SLC12A1 KCNT2	1.66e-06	160	226	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 KCNV2 RYR2 CPVL FRAS1 COL12A1 SLC12A1 KCNT2	1.66e-06	160	226	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ILDR2 NET1 RNF112 CSDC2 FREM2 FRAS1 FREM3 TNXB	3.10e-06	174	226	8	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRS1 NELL1 BSN FAM135A FRAS1 FRYL ANKRD60 AKAP11	3.10e-06	174	226	8	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RASGRP3 PCDHB14 RASGEF1A RGS12 CELSR2 TJP1 PCDH1 CDH5	4.15e-06	181	226	8	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 RYR2 FREM2 FAT1 NRK FAT4 FRAS1 COL12A1	4.69e-06	184	226	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 RYR2 FREM2 FAT1 NRK FAT4 FRAS1 COL12A1	4.69e-06	184	226	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 RYR2 FREM2 FAT1 NRK FAT4 FRAS1 COL12A1	4.69e-06	184	226	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ILDR2 NET1 HLA-DOA RASSF2 CPVL FAM135A PCDHGA4 C1orf115	4.69e-06	184	226	8	a6f8b42982ec0cf44b950a2cd9715d068eec4ecb
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	ACACB GCNT2 CSDC2 GRAMD1B RASGRP3 CPVL MYOM3 PATJ	5.49e-06	188	226	8	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NR6A1 ADSS2 NRK FAM135A COL12A1 NECTIN3 MYOF PATJ	5.49e-06	188	226	8	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	BRINP3 IRS1 ITGA9 FAT1 NHS FAT4 COL12A1 KCNT2	5.71e-06	189	226	8	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	droplet-Heart-nan-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRAMD1B RHPN1 KCNA1 COL12A1 RASGEF1A FAAP100 AATK CELSR2	5.71e-06	189	226	8	0493f7b79127c207fd7ade778ef4810500495d7e
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	BRINP3 NRK FAT4 COL12A1 AOX1 IGDCC4 KCNT2 TNXB	6.41e-06	192	226	8	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 MYOF FIBCD1 KNDC1	6.41e-06	192	226	8	7bcdbd97fa8c3bfccde426d44979601226913fc3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 DMXL2 MYOF KNDC1	7.18e-06	195	226	8	157f1f9b0521c9eba11806eb4b6802ff116ab912
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 DMXL2 MYOF KNDC1	7.18e-06	195	226	8	95327f2818bcdca53dbd2971f674a9042a1392c6
ToppCell	COVID-19_Moderate-Non-classical_Monocyte\|COVID-19_Moderate / disease group, cell group and cell class	PIK3AP1 SERPINA1 FCGR3A ARAP1 AMPD2 DMXL2 RGS12 MYOF	7.45e-06	196	226	8	256c557fa11414c9d2cbb1fcff33f482ee1c78ac
ToppCell	COVID-19_Severe-Non-classical_Monocyte\|COVID-19_Severe / disease group, cell group and cell class	PIK3AP1 SERPINA1 FCGR3A ARAP1 AMPD2 DMXL2 RGS12 MYOF	7.45e-06	196	226	8	af9e8f5ef9d03862f707e105857309b55595b1b9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 SERPINA1 FAT1 NHS PLEKHA7 TNS3 FRAS1 PATJ	7.73e-06	197	226	8	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	COVID-19_Severe-Myeloid-Non-classical_Monocyte\|COVID-19_Severe / Disease group, lineage and cell class	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	7.73e-06	197	226	8	c5837b9a5a39a0f607a4e217ade9fc87d82a5406
ToppCell	COVID-19_Severe-Non-classical_Monocyte\|World / disease group, cell group and cell class	PIK3AP1 SERPINA1 FCGR3A ARAP1 AMPD2 DMXL2 RGS12 MYOF	7.73e-06	197	226	8	60fee75b12451206bb2c07b61651a73c59ec6ade
ToppCell	PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	8.02e-06	198	226	8	d36a3cda7e5f385d2391e9b0dfb027d3c4549320
ToppCell	PBMC-Severe-Myeloid-Non-classical_Monocyte\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	8.02e-06	198	226	8	5436c3ed16e10e00c686f1ab0b0a68728a1a9985
ToppCell	PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	8.02e-06	198	226	8	4f67067d8142ca11b2d80195dac8d62a8d24d52c
ToppCell	PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	8.02e-06	198	226	8	9b8679b3dd8f4220d71f607b7080cb88d6e71129
ToppCell	PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	8.02e-06	198	226	8	8b6b602ebe59b6dca6a22f17385d3160ff3ac67e
ToppCell	PBMC-Severe-Myeloid-Non-classical_Monocyte\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	8.02e-06	198	226	8	b9030390316baf456135f85f831394e1e11ecf3e
ToppCell	COVID-19_Moderate-Non-classical_Monocyte\|World / disease group, cell group and cell class	PIK3AP1 SERPINA1 FCGR3A ARAP1 AMPD2 DMXL2 RGS12 MYOF	8.02e-06	198	226	8	8449934e20bb2a34079fb642cae0d4647b9efe51
ToppCell	COVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte\|COVID-19_Severe / Disease, condition lineage and cell class	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF KNDC1	8.63e-06	200	226	8	58fbb7fc7159cbc417e6b457d60b7beba9b90da6
ToppCell	mild-Non-classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PIK3AP1 SERPINA1 FCGR3A CPVL ARAP1 AMPD2 DMXL2 MYOF	8.63e-06	200	226	8	334bab6bf93d455f3526e817ea5785d8b6ee531c
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHACTR2 NET1 RYR1 NFKB1 DPP4 COL17A1 PCDHGC5	1.86e-05	161	226	7	ed93cb6c133855a5c244821e1a260aae8ab4df9a
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHACTR2 NET1 RYR1 NFKB1 DPP4 COL17A1 PCDHGC5	1.86e-05	161	226	7	0089d7bb305c592392791862a3341fc92af8f3e2
ToppCell	COVID-19_Convalescent-cDC\|COVID-19_Convalescent / Disease condition and Cell class	ILDR2 HLA-DOA SIDT1 GGT7 JAKMIP1 COL17A1 RGPD8	2.74e-05	171	226	7	9ccaa9f1629818b0f63a5d930ee78c01e04cd98d
ToppCell	COVID-19_Convalescent-cDC-\|COVID-19_Convalescent / Disease condition and Cell class	ILDR2 HLA-DOA SIDT1 GGT7 JAKMIP1 COL17A1 RGPD8	2.74e-05	171	226	7	fb5fae8b3adafcbb7c5618d887966b418355ed4d
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	PIK3AP1 RBM44 HLA-DOA CPVL AMPD2 SHLD1 DCHS1	2.95e-05	173	226	7	8384d533a1071fc65a06e6d9f5f17d8ab00c3966
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ILDR2 NET1 RNF112 FREM2 FRAS1 FREM3 TNXB	2.95e-05	173	226	7	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	CATSPERE USP32 HELZ RANBP2 FAAP100 MFN1 SNIP1	3.06e-05	174	226	7	2274648b80dd74f3c948a779bba3391095964c34
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRASP1 PEG3 RYR2 RANBP2 AZI2 ZNF106 KCNT2	3.30e-05	176	226	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 IRS1 NELL1 BSN FAM135A FRAS1 AKAP11	3.54e-05	178	226	7	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ITGA9 FAT1 NHS FRAS1 CRTAC1 PATJ RNF39	3.80e-05	180	226	7	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3AP1 NRK TNS3 FRAS1 COL12A1 RGS12 PATJ	3.94e-05	181	226	7	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3AP1 NRK TNS3 FRAS1 COL12A1 RGS12 PATJ	4.08e-05	182	226	7	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	RYR2 RASGRP3 RASGEF1A C1orf115 TJP1 PCDH1 CDH5	4.08e-05	182	226	7	fec1caf867b1dc87b24504d895ee1a27df78062e
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTB ITGA9 RYR2 CSDC2 GRAMD1B RASGRP3 MYOM3	4.22e-05	183	226	7	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NET1 HLA-DOA RASSF2 CPVL FAM135A PCDHGA4 C1orf115	4.37e-05	184	226	7	667846c422cfa27e949a24844a305df859cb6760
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	PIK3AP1 SERPINA1 FAT1 VPS13A NHS AOX1 MYOM3	4.37e-05	184	226	7	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDHR5 FOXN3 GRAMD1B C8A DPP4 C1orf115 AATK	4.68e-05	186	226	7	bdd9d3a432aab46e733469b362f0064d35c1ac49
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NR6A1 ITGA9 PLEKHA7 FRAS1 NECTIN3 MYOF PATJ	4.68e-05	186	226	7	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDHR5 FOXN3 GRAMD1B C8A DPP4 C1orf115 AATK	4.84e-05	187	226	7	9042bd0f57213a51503d9df2e4dce3209b7772d3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3AP1 GCNT2 SERPINA1 DPP4 FRAS1 RGS12 PATJ	4.84e-05	187	226	7	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	ACACB GCNT2 CSDC2 GRAMD1B RASGRP3 MYOM3 PATJ	4.84e-05	187	226	7	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GCNT2 NHS PLEKHA7 FAT4 COL12A1 RGS12 IGDCC4	4.84e-05	187	226	7	02105c82a9ba79d2f19e002188377fc3440770c2
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BRINP3 IRS1 ITGA9 FAT1 NHS COL12A1 KCNT2	4.84e-05	187	226	7	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB EML6 NELL1 MKLN1 PLEKHA7 SLC12A1 PATJ	5.18e-05	189	226	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHACTR2 NET1 PEG3 NRK PDIA5 DPP4 COMP	5.18e-05	189	226	7	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ACACB GCNT2 RYR2 CSDC2 GRAMD1B MYOM3 PATJ	5.18e-05	189	226	7	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NET1 SPTB RYR2 FAT1 NHS COL12A1 NPAS4	5.36e-05	190	226	7	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	METAP1D GCNT2 NHS FAT4 RGS12 IGDCC4 KCNT2	5.54e-05	191	226	7	764c3a8829ae1253a0790744138266e81fc075ec
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PEG3 IRS1 RYR2 FAT1 ARHGEF25 MYOF KCNT2	5.54e-05	191	226	7	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RASSF2 SIDT1 RASGRP3 CARTPT C1orf115 PCDH1 CDH5	5.54e-05	191	226	7	e3fc5c92491b6e334abffbf085c00a0b5fa1aed2
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BRINP3 HMCN2 NRK COL12A1 IGDCC4 KCNT2 TNXB	5.72e-05	192	226	7	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA9 RAD51 PCDHB14 MYOF DCHS1 CDH5 TNXB	5.72e-05	192	226	7	a42aed9e563f5f4af029b8804c104f11ad227a8f
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 RASGEF1A NECTIN3 RGS12 TJP1 PCDH1 CDH5	5.72e-05	192	226	7	35f7926628a967f85b26371e795a1b93c6f103ab
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B NHS PLEKHA7 FRAS1 SBF2 PATJ VPS13B	5.72e-05	192	226	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	METAP1D GCNT2 NHS FAT4 RGS12 IGDCC4 KCNT2	5.72e-05	192	226	7	3abee376c37c3646da33ac381aa63d50a01607a6
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB PABPC4 RYR2 CSDC2 FRAS1 PPP1R3A TNNI3K	5.72e-05	192	226	7	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	GCNT2 ITGA9 FAT1 NHS TJP1 PATJ RNF39	5.72e-05	192	226	7	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	ACACB GCNT2 RYR2 CSDC2 RASGRP3 MYOM3 PATJ	5.72e-05	192	226	7	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB PABPC4 RYR2 CSDC2 FRAS1 PPP1R3A TNNI3K	5.72e-05	192	226	7	d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell	mild_COVID-19_(asymptomatic)-Non-classical_Monocyte\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	PIEZO1 SERPINA1 FCGR3A ARAP1 RGS12 MYOF KNDC1	5.91e-05	193	226	7	7839040e703877ef321494ad8926a8604729ceda
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FOXN3 PLEKHA7 TNS3 RGPD8 NUP98 SBF2 VPS13B	5.91e-05	193	226	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FOXN3 RASGRP3 FAM135A FAT4 CASK SBF2 CDH5	5.91e-05	193	226	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	BRINP3 RYR2 NHS FAT4 COL12A1 COMP KCNT2	5.91e-05	193	226	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	PND10-Endothelial-Endothelial_blood-vessel\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 PCDH1 CDH5	5.91e-05	193	226	7	1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 PCDH1 CDH5	5.91e-05	193	226	7	b7c0b4dbbe11f86cff6371d3d12a6b772b938d78
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 PCDH1 CDH5	5.91e-05	193	226	7	e44d777f65b907f299cefd73296805ac4c92d383
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 PCDH1 CDH5	5.91e-05	193	226	7	097a244cf37ce6c1ace9bae56beb7de59442cd6b
ToppCell	droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDIA5 TNS3 COL12A1 NECTIN3 RGS12 PCDH1 CDH5	5.91e-05	193	226	7	3a5ad8ffad441e30a6e1bd017da7720ad57f6c57
ToppCell	PND10-Endothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 PCDH1 CDH5	5.91e-05	193	226	7	f3c743b340fc588bc8effd375b12e2c7cbfa49d2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 FREM2 FAT1 PLEKHA7 FRAS1 SLC12A1 PATJ	6.11e-05	194	226	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	severe_influenza-Non-classical_Monocyte\|severe_influenza / disease group, cell group and cell class (v2)	PIK3AP1 PABPC4 SERPINA1 FCGR3A AMPD2 RGS12 KNDC1	6.11e-05	194	226	7	7630e223666fb65743e21e045478f687dd739a54
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 FREM2 FAT1 NHS PLEKHA7 FRAS1 PATJ	6.11e-05	194	226	7	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PEG3 RASGRP3 RASGEF1A RGS12 TJP1 PCDH1 CDH5	6.11e-05	194	226	7	44c7d4b75f3b7c9301eba20610e548a01a84ae40
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PEG3 RASGRP3 RASGEF1A RGS12 TJP1 PCDH1 CDH5	6.11e-05	194	226	7	7f24023df47935286f185dd428d48797daf26f49
ToppCell	droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL12A1 RASGEF1A NECTIN3 RGS12 TJP1 PCDH1 CDH5	6.11e-05	194	226	7	cf7f232827945fbafd2c298c08a799ab916c2472
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PEG3 RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 CDH5	6.11e-05	194	226	7	1b382508453c5b08fb617f626b230adf3b6cff99
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 FAT1 NHS PLEKHA7 FAM135A FRAS1 PATJ	6.11e-05	194	226	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	PND07-Endothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 PCDH1 CDH5	6.11e-05	194	226	7	d1080c86884916c22894b27994141463f5919812
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHACTR2 RASGRP3 RASGEF1A RGS12 TJP1 PCDH1 CDH5	6.31e-05	195	226	7	e5f14f6015ea5e6fa065f906ad22157e3de15c68
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 GCNT2 NHS PLEKHA7 FRAS1 SLC12A1 PATJ	6.31e-05	195	226	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	RYR2 GRAMD1B DPP4 NUP98 CASP8 CASK SETD7	6.31e-05	195	226	7	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PEG3 RASGRP3 RASGEF1A RGS12 C1orf115 TJP1 CDH5	6.31e-05	195	226	7	cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCell	Influenza_Severe-Non-classical_Monocyte\|World / Disease group and Cell class	PIK3AP1 SERPINA1 FCGR3A CPVL AMPD2 RGS12 MYOF	6.52e-05	196	226	7	8ef9810ee99082a9c803c7ecad6ceb5710d16b54
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ATP6V1A HIBCH TUBGCP3 PGBD5 ARAP1 CASP8 RGS12 VPS13D XPNPEP3 SUGP1 PATJ STX16	4.03e-07	189	224	12	3262_DN
Drug	Caffeic acid [3331-39-5]; Down 200; 22.2uM; PC3; HT_HG-U133A	UBE4B GCNT2 SERGEF HELZ TMED2 VGLL1 GPD2 CASP8 MFN1 TRMU CELSR3 STX16	5.05e-07	193	224	12	6753_DN
Drug	Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HT_HG-U133A	PCYT1A DCAF8 UBE4B SERGEF HELZ TMED2 GPD2 CASP8 XPNPEP3 SUGP1 STX16	3.72e-06	194	224	11	6756_DN
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	GPRASP1 KPNA6 FOXN3 NR6A1 RYR1 C8A ARAP1 RAD51 JADE2 SBNO2 MYOF	3.91e-06	195	224	11	5468_UP
Drug	Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; PC3; HT_HG-U133A	PCYT1A DCAF8 UBE4B ZBTB43 CSRNP3 TMED2 ARAP1 GPD2 CASP8 SUGP1 STX16	3.91e-06	195	224	11	6754_DN
Drug	Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; PC3; HT_HG-U133A	GPRASP1 TBC1D9B KPNA6 SQSTM1 AP5Z1 HPS4 SNIP1 THBS3 XPNPEP3 ANXA10 VPS13B	4.11e-06	196	224	11	7141_DN
Drug	Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	ZBTB43 SERPINA1 TUBGCP3 ARAP1 PLXNA3 DPP4 KAT6A CASP8 THBS3 VPS13D STX16	4.53e-06	198	224	11	5742_DN
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; PC3; HT_HG-U133A	TBC1D9B UBE4B ZBTB43 KPNA6 CSRNP3 CLK1 SQSTM1 AP5Z1 VPS13D OPTN ZNF839	4.99e-06	200	224	11	6284_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	BRINP3 GLS2 SIDT1 IRS1 AP5Z1 NFKB1 JADE2 SBNO2 MYOF SUGP1	9.19e-06	174	224	10	5945_DN
Drug	NPOH	ADHFE1 GPD2 CASP8	1.84e-05	6	224	3	CID000070194
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	ATP6V1A GLS2 POGZ SERGEF TMED2 CASP8 SBNO2 XPNPEP3 STX16 PCDH1	2.07e-05	191	224	10	4298_DN
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A	ATP6V1A UBE4B ALDH18A1 HELZ TMED2 GPD2 CASP8 MFN1 THBS3 SUGP1	2.26e-05	193	224	10	6716_DN
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	GPRASP1 GLS2 NR6A1 CLK1 HPS4 PGBD5 RANBP2 CASP8 CASK PATJ	2.36e-05	194	224	10	3316_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	KIAA0586 AP5Z1 VPS13A GPD2 RANBP2 DMXL2 JADE2 VPS13D XPNPEP3 SUGP1	2.36e-05	194	224	10	1822_DN
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	RASSF2 KIAA0586 RYR2 GPD2 DPP4 FAAP100 MYOF THBS3 SUGP1 KDM7A	2.58e-05	196	224	10	5016_DN
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; PC3; HT_HG-U133A	PEG3 ZBTB43 SERPINA1 TUBGCP3 VGLL1 ARAP1 CASP8 TRMU ZNF839 VPS13B	2.58e-05	196	224	10	5733_DN
Drug	Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; PC3; HT_HG-U133A	TBC1D9B GLS2 ACACB GRAMD1B SBNO2 LIMK1 VPS13D XPNPEP3 SUGP1 ZNF839	2.70e-05	197	224	10	4608_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; HL60; HG-U133A	ACACB PIEZO1 NR6A1 VPS13A FAAP100 MFN1 THBS3 AATK SND1 ZNF839	2.82e-05	198	224	10	1740_UP
Drug	3-nitropropanol	ADHFE1 GPD2 CASP8	3.19e-05	7	224	3	CID000032832
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PCYT1A KIAA0586 KPNA6 VPS13A HELZ NUP98 MFN1 VPS13D TRABD	7.67e-05	180	224	9	2859_DN
Drug	scriptaid; Down 200; 10uM; PC3; HT_HG-U133A	DCAF8 ACACB SIDT1 IRS1 HPS4 TUBGCP3 JADE2 MYOF SUGP1	8.34e-05	182	224	9	6896_DN
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	TBC1D9B KIAA0586 IRS1 DPP4 JADE2 TRMU THBS3 VPS13D ZNF839	8.34e-05	182	224	9	1231_DN
Drug	PMME	PCYT1A PCYT1B	9.64e-05	2	224	2	CID000439436
Drug	AC1NQVPA	RAD51 MMUT	9.64e-05	2	224	2	CID005229480
Drug	2f34	UBR1 PGM3 SQSTM1 UFD1 RANBP2 NUP98 NGLY1 MMUT NPAS4	1.07e-04	188	224	9	CID006420160
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A	ATP6V1A PHACTR2 UBE4B HELZ TMED2 DPP4 CASP8 MFN1 SUGP1	1.11e-04	189	224	9	6750_DN
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A	ACACB PEG3 DPP4 MFN1 CASK TRMU SNIP1 THBS3 VPS13D	1.16e-04	190	224	9	7305_DN
Drug	DNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A	GLS2 FOXN3 CSRNP3 HPS4 SERGEF PLXNA3 VPS13D OPTN PATJ	1.25e-04	192	224	9	7548_UP
Drug	rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A	ACACB UBE4B CSRNP3 TRMU MYOF C1orf115 VPS13D SUGP1 TMEM40	1.30e-04	193	224	9	1233_DN
Drug	Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A	ATP6V1A UBE4B TMED2 FAT4 CASP8 MFN1 TRABD SUGP1 KDM7A	1.30e-04	193	224	9	6704_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	HPS4 TMED2 ARAP1 RAD51 GPD2 KAT6A CASP8 RGS12 SUGP1	1.36e-04	194	224	9	3606_DN
Drug	BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A	ACACB POGZ AP5Z1 HPS4 VPS13A FAAP100 TRMU ZNF839 MMUT	1.36e-04	194	224	9	6876_DN
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; HL60; HT_HG-U133A	KIAA0586 RYR2 ARAP1 KAT6A FAAP100 SBNO2 MYOF CELSR2 SUGP1	1.41e-04	195	224	9	2163_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	POGZ GCNT2 RYR2 RAD51 GPD2 JADE2 CELSR3 XPNPEP3 SUGP1	1.41e-04	195	224	9	2283_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	GLS2 UBE4B ZBTB43 PLXNA3 TRMU OPTN CELSR3 SUGP1 PATJ	1.41e-04	195	224	9	5329_DN
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A	UBE4B FOXN3 SERPINA1 AP5Z1 TMED2 FAT4 CASP8 FAAP100 SUGP1	1.41e-04	195	224	9	6707_DN
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A	GLS2 FOXN3 RYR2 ARAP1 KAT6A AOX1 MYOF SUGP1 PATJ	1.41e-04	195	224	9	4386_DN
Drug	2,3,6,2',3',6'-hexachlorobiphenyl	RYR1 RYR2 PPP1R9B	1.46e-04	11	224	3	ctd:C010498
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; HL60; HG-U133A	ATP6V1A ABCF3 KIAA0586 POGZ FOXN3 KPNA1 CASP8 VPS13D STX16	1.47e-04	196	224	9	1735_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	SERPINA1 VPS13A NUP98 FAAP100 TRMU VPS13D AATK SND1 ZNF839	1.47e-04	196	224	9	6610_DN
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	DCAF8 ACACB ZBTB43 KPNA6 RAD51 DPP4 FAAP100 TRMU SUGP1	1.47e-04	196	224	9	5863_DN
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A	HPS4 PGBD5 CASP8 SBNO2 MYOF OPTN TRABD SUGP1 PATJ	1.47e-04	196	224	9	5007_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A	SQSTM1 HPS4 DPP4 NECTIN3 RGS12 LIMK1 VPS13D CELSR3 SND1	1.52e-04	197	224	9	7411_UP
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	DCAF8 PEG3 TUSC2 VGLL1 COL17A1 SBNO2 VPS13D TRABD SUGP1	1.52e-04	197	224	9	6428_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A	ACACB ZBTB43 KPNA6 RYR2 DPP4 TRMU SUGP1 ZNF839 MMUT	1.52e-04	197	224	9	5865_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A	NET1 SIDT1 FOXN3 PGM3 HIBCH TMED2 CASP8 THBS3 STX16	1.52e-04	197	224	9	1311_DN
Drug	Molsidomine [25717-80-0]; Down 200; 16.6uM; PC3; HT_HG-U133A	ACACB ZBTB43 TUSC2 SBNO2 NBAS THBS3 XPNPEP3 SUGP1 ZNF839	1.52e-04	197	224	9	6325_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BRINP3 GLS2 SIDT1 KPNA6 POGZ TUBGCP3 SBNO2 SND1 TRABD	1.58e-04	198	224	9	3332_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	GPRASP1 PIEZO1 ZBTB43 AP5Z1 HPS4 VPS13A CASP8 CELSR2 PATJ	1.58e-04	198	224	9	6976_UP
Drug	Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	GLS2 FOXN3 RAD51 ZNF419 MYOF VPS13D SUGP1 PATJ PCDH1	1.58e-04	198	224	9	6083_DN
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	TBC1D9B DCAF8 UBE4B ZBTB43 ARAP1 SNIP1 VPS13D SUGP1 ZNF839	1.58e-04	198	224	9	6928_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ACACB ZBTB43 SQSTM1 HPS4 HELZ RAD51 GPD2 TRMU PATJ	1.58e-04	198	224	9	3175_DN
Drug	(+/-)-thalidomide; Up 200; 100uM; MCF7; HG-U133A	UBE4B PGM3 DLEC1 PGBD5 ARAP1 PCYT1B SBNO2 SND1 ZNF839	1.58e-04	198	224	9	266_UP
Drug	Chlorzoxazone [95-25-0]; Down 200; 23.6uM; PC3; HT_HG-U133A	TBC1D9B UBE4B TUBGCP3 ARAP1 DPP4 FRYL VPS13D OPTN KDM7A	1.58e-04	198	224	9	2100_DN
Drug	16, 16-dimethylprostaglandin E2 methyl acetate solution; Up 200; 10uM; MCF7; HT_HG-U133A	ACACB TUSC2 AP5Z1 FAAP100 TRMU VPS13D SND1 SUGP1 ZNF839	1.58e-04	198	224	9	6597_UP
Drug	Bezafibrate [41859-67-0]; Down 200; 11uM; MCF7; HT_HG-U133A	UBE4B HPS4 TMED2 GPD2 FAAP100 MFN1 TRMU MYOF TRABD	1.58e-04	198	224	9	4999_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	GLS2 SIDT1 RYR2 AOX1 SBNO2 THBS3 SUGP1 KDM7A PATJ	1.58e-04	198	224	9	3311_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; PC3; HT_HG-U133A	POGZ SQSTM1 AP5Z1 ARAP1 SBNO2 THBS3 TRABD SUGP1 ZNF839	1.58e-04	198	224	9	2096_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A	TBC1D9B DCAF8 UBE4B RYR2 AMPD2 MFN1 VPS13D SUGP1 STX16	1.58e-04	198	224	9	5878_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	UBE4B ZBTB43 POGZ TUBGCP3 PLXNA3 DPP4 SBNO2 XPNPEP3 MMUT	1.58e-04	198	224	9	4567_DN
Drug	Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	RASSF2 JADE2 KAT6A CASP8 MYOF THBS3 VPS13D SND1 SUGP1	1.58e-04	198	224	9	2274_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A	ZBTB43 FOXN3 RYR2 AP5Z1 FAAP100 SBNO2 MYOF SUGP1 PATJ	1.58e-04	198	224	9	3706_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	RYR2 SERPINA1 HPS4 PGBD5 ARAP1 NUP98 TRMU SNIP1 VPS13D	1.58e-04	198	224	9	6444_DN
Drug	oxaloacetate	GLS2 PDHA2 PGM3 GGT7 SERPINA1 ADHFE1 ALDH18A1 TALDO1 GPD2	1.58e-04	198	224	9	CID000000970
Drug	Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	PEG3 ZBTB43 FOXN3 AP5Z1 ARAP1 AOX1 SBNO2 SUGP1 DEPDC5	1.64e-04	199	224	9	6240_UP
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	GLS2 ZBTB43 POGZ HPS4 ARAP1 JADE2 KAT6A SBNO2 ZNF419	1.64e-04	199	224	9	2319_DN
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; HL60; HT_HG-U133A	ZBTB43 SIDT1 TUSC2 FOXN3 AP5Z1 HPS4 ARAP1 MYOF ZNF839	1.64e-04	199	224	9	1318_DN
Drug	Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	DCAF8 TUSC2 PHKB CLK1 TRMU SNIP1 XPNPEP3 SUGP1 MMUT	1.64e-04	199	224	9	4778_DN
Drug	Brinzolamide [138890-62-7]; Up 200; 10.4uM; HL60; HG-U133A	SRP72 PGM3 CLK1 HPS4 TMED2 SIRT1 MFN1 ZNF419 MYOF	1.64e-04	199	224	9	1615_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	GPRASP1 ACACB KPNA6 DPP4 FAT4 NUP98 FAAP100 SNIP1 SUGP1	1.64e-04	199	224	9	6308_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	DCAF8 ACACB PIEZO1 FOXN3 HPS4 ARAP1 LIMK1 VPS13D CELSR3	1.71e-04	200	224	9	3322_UP
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	TBC1D9B ZBTB43 DPP4 SNIP1 C1orf115 THBS3 VPS13D OPTN XPNPEP3	1.71e-04	200	224	9	5883_DN
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; PC3; HT_HG-U133A	PHACTR2 ZBTB43 TUSC2 GCNT2 PHKB HIBCH DPP4 MYOF STX16	1.71e-04	200	224	9	7315_DN
Disease	Van Maldergem Wetzburger Verloes syndrome	FAT4 DCHS1	5.28e-05	2	215	2	C1832390
Disease	Van Maldergem syndrome	FAT4 DCHS1	5.28e-05	2	215	2	cv:C1832390
Disease	Periventricular gray matter heterotopia	FAT4 DCHS1	5.28e-05	2	215	2	C1849173
Disease	Colorectal Carcinoma	RASSF2 PEG3 CSMD3 NELL1 FAT1 KCNA10 CSRNP3 VPS13A JAKMIP1 CAD CASP8 ABCB6 MFN1 TNNI3K DCHS1 CDH5	6.28e-05	702	215	16	C0009402
Disease	GDH/6PGL endoplasmic bifunctional protein measurement	SERPINA1 OVCH1 SUGP1	1.31e-04	14	215	3	EFO_0801619
Disease	Cryptophthalmos syndrome	FREM2 FRAS1	1.58e-04	3	215	2	C0265233
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	1.58e-04	3	215	2	DOID:3529 (implicated_via_orthology)
Disease	autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)	VPS13A VPS13D	1.58e-04	3	215	2	DOID:0111611 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	1.58e-04	3	215	2	DOID:8545 (implicated_via_orthology)
Disease	Cohen syndrome (implicated_via_orthology)	VPS13A VPS13B	1.58e-04	3	215	2	DOID:0111590 (implicated_via_orthology)
Disease	FRASER SYNDROME 1	FREM2 FRAS1	1.58e-04	3	215	2	C4551480
Disease	infantile liver failure syndrome (is_implicated_in)	TRMU NBAS	1.58e-04	3	215	2	DOID:0080716 (is_implicated_in)
Disease	Heterotopia, Periventricular, Autosomal Recessive	FAT4 DCHS1	1.58e-04	3	215	2	C1842563
Disease	epilepsy (implicated_via_orthology)	KCNA1 KCNA10 BSN SLC12A1 KCNT2 SBF2 DEPDC5	2.02e-04	163	215	7	DOID:1826 (implicated_via_orthology)
Disease	reticulocyte count	GLS2 PIEZO1 SPTB EML6 IRS1 NELL1 SERPINA1 FAT1 NFKB1 USP32 VPS13A BSN PLEKHA7 TNS3 ABCB6 SBNO2 DEPDC5 RNF39 CDH5	2.52e-04	1045	215	19	EFO_0007986
Disease	reticulocyte measurement	GLS2 PIEZO1 SPTB EML6 IRS1 GGT7 SERPINA1 FAT1 NFKB1 USP32 VPS13A BSN PLEKHA7 TNS3 ABCB6 SBNO2 TRMU SBF2 DEPDC5	2.77e-04	1053	215	19	EFO_0010700
Disease	serum hepcidin measurement	EML6 NELL1 AKAP11	2.87e-04	18	215	3	EFO_0004504
Disease	pulmonary hypertension (biomarker_via_orthology)	RYR1 RYR2 MFN1 CDH5 HDAC1	3.02e-04	80	215	5	DOID:6432 (biomarker_via_orthology)
Disease	Fraser syndrome (implicated_via_orthology)	FREM2 FRAS1	3.14e-04	4	215	2	DOID:0090001 (implicated_via_orthology)
Disease	Wallerian Degeneration	UBE4B SIRT1	3.14e-04	4	215	2	C0043020
Disease	Malignant neoplasm of breast	TBC1D9B CATSPERE NET1 ITGA9 PIK3R4 PHKB ADHFE1 NHS DLEC1 RAD51 NUP98 CASP8 ABCB6 SIRT1 PPP1R3A THBS3 KCNT2 CDH5 VPS13B	3.54e-04	1074	215	19	C0006142
Disease	Paget's disease of bone (is_implicated_in)	SQSTM1 OPTN	5.21e-04	5	215	2	DOID:5408 (is_implicated_in)
Disease	generalised epilepsy	GLS2 RYR2 HPS4 TRIM36	5.64e-04	52	215	4	EFO_0005917
Disease	semenogelin-1 measurement	DNAAF3 C8A	7.78e-04	6	215	2	EFO_0802051
Disease	Obesity	ACACB IRS1 BBS5 SIRT1 CARTPT VPS13B MMUT	7.98e-04	205	215	7	C0028754
Disease	cortical surface area measurement	ILDR2 GLS2 SIDT1 RGPD1 DNAAF3 NELL1 SERPINA1 NFKB1 PPP1R9B PLEKHA7 CPVL DPP4 RASGEF1A CRTAC1 FRYL NECTIN3 ACTR1A ZNF106 SND1 TJP1 TNXB	8.82e-04	1345	215	21	EFO_0010736
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	BSN CELSR3	1.08e-03	7	215	2	EFO_0020797
Disease	hereditary spastic paraplegia (is_implicated_in)	AP5Z1 ALDH18A1	1.08e-03	7	215	2	DOID:2476 (is_implicated_in)
Disease	lymphocyte count	PIK3AP1 UBE4B HLA-DOA PIEZO1 SPTB EML6 GCNT2 GRAMD1B SQSTM1 NFKB1 ALDH18A1 HELZ FRAS1 PCDHGC5 PCDHGA4 CASP8 GSX2 SBNO2 SLC12A1 PCDHGA12 RNF39 RPA2	1.09e-03	1464	215	22	EFO_0004587
Disease	stimulant use measurement	DLEC1 FAM135A NBAS	1.09e-03	28	215	3	EFO_0600076
Disease	TYPE 2 DIABETES MELLITUS	IRS1 GPD2 PPP1R3A	1.09e-03	28	215	3	125853
Disease	Type 2 diabetes mellitus	IRS1 GPD2 PPP1R3A	1.09e-03	28	215	3	cv:C0011860
Disease	Diabetes Mellitus, Non-Insulin-Dependent	IRS1 NFKB1 GPD2 JADE2 CASP8 SIRT1 PPP1R3A	1.23e-03	221	215	7	C0011860
Disease	syndromic X-linked intellectual disability (implicated_via_orthology)	CASK KDM7A	1.44e-03	8	215	2	DOID:0060309 (implicated_via_orthology)
Disease	Hereditary spherocytosis	SPTB CAD	1.44e-03	8	215	2	C0037889
Disease	Unilateral agenesis of kidney	FREM2 FRAS1	1.44e-03	8	215	2	C0266294
Disease	fatty liver disease (implicated_via_orthology)	ACACB NFKB1 SIRT1	1.48e-03	31	215	3	DOID:9452 (implicated_via_orthology)
Disease	intelligence, self reported educational attainment	BSN TRIM36 GPD2 DPP4 CELSR3	1.70e-03	117	215	5	EFO_0004337, EFO_0004784
Disease	keratinocyte carcinoma	HLA-DOA CPVL TNS3 CASP8 SBNO2	1.76e-03	118	215	5	EFO_0010176
Disease	opioid dependence	RBM44 CSMD3 NELL1 DLEC1 DPP4 FAT4 CARTPT	1.84e-03	237	215	7	EFO_0005611
Disease	Osteitis Deformans	SQSTM1 OPTN	1.84e-03	9	215	2	C0029401
Disease	alpha-1-antitrypsin measurement	SERPINA1 CELSR2	1.84e-03	9	215	2	EFO_0008327
Disease	Ceroid lipofuscinosis, neuronal 1, infantile	SIRT1 MFN1	2.29e-03	10	215	2	C2931673
Disease	proteinuria (biomarker_via_orthology)	SERPINA1 OPTN	2.29e-03	10	215	2	DOID:576 (biomarker_via_orthology)
Disease	Methylmalonic acidemia	GPD2 MMUT	2.29e-03	10	215	2	C0268583
Disease	Nephroblastoma	NHS NBAS	2.29e-03	10	215	2	Orphanet_654
Disease	phosphatidylcholine 32:1 measurement	NELL1 SHLD1 DCHS1	2.67e-03	38	215	3	EFO_0010373
Disease	creatinine measurement	RNF112 RYR1 GGT7 NELL1 NFKB1 USP32 DLEC1 BSN PLEKHA7 RGS12 SBNO2 PPP1R3A THBS3 CELSR3 CELSR2 SND1	2.71e-03	995	215	16	EFO_0004518
Disease	Methylmalonic aciduria	GPD2 MMUT	2.78e-03	11	215	2	C1855119
Disease	corpus callosum anterior volume measurement	PPP1R9B JAKMIP1 SND1	2.87e-03	39	215	3	EFO_0010295
Disease	complement C1q tumor necrosis factor-related protein 1 measurement	SERPINA1 CELSR2	3.32e-03	12	215	2	EFO_0801493
Disease	cortical thickness	ABCF3 GLS2 SIDT1 DNAAF3 NELL1 SERPINA1 NFKB1 DLEC1 TRIM36 PLEKHA7 CPVL DPP4 COL12A1 ZNF106 THBS3 VPS13D SND1	3.40e-03	1113	215	17	EFO_0004840
Disease	mean platelet volume	PCYT1A LRRC66 GLS2 EML6 SIDT1 IRS1 GRAMD1B PDIA5 ARAP1 PCDHGC5 PCDHGA4 FRYL RGS12 TRMU PCDHGA12 TRABD	3.45e-03	1020	215	16	EFO_0004584
Disease	parental longevity	PIK3AP1 NELL1 AP5Z1 VPS13A JAKMIP1 BSN SHLD1 RGS12 TNNI3K CELSR2	3.54e-03	494	215	10	EFO_0007796
Disease	IGFBP-1 measurement	NELL1 ADSS2	3.91e-03	13	215	2	EFO_0005118
Disease	Congenital pontocerebellar hypoplasia	AMPD2 CASK	3.91e-03	13	215	2	C0266468
Disease	FEV/FEC ratio	DCAF8 PABPC4 KIAA0586 FREM2 SERPINA1 FCGR3A RASGRP3 DLEC1 CPVL ARAP1 FRAS1 GSX2 ZNF106 LIMK1 THBS3 SBF2 KDM7A TNXB	4.00e-03	1228	215	18	EFO_0004713
Disease	HbA1c measurement	ACACB PIEZO1 SPTB FOXN3 VPS13A BSN CPVL ARAP1 CASP8 FREM3 SND1 SBF2	4.15e-03	675	215	12	EFO_0004541
Disease	Heart Diseases	BSN SIRT1 HDAC1	4.60e-03	46	215	3	C0018799
Disease	response to paliperidone, schizophrenia symptom severity measurement	BRINP3 PHACTR2 CSMD3 NELL1 SERPINA1 HIBCH	5.18e-03	216	215	6	EFO_0007925, EFO_0007927
Disease	Squamous cell carcinoma of esophagus	FAT1 DLEC1 FAT4 TNXB	5.20e-03	95	215	4	C0279626
Disease	hepcidin:transferrin saturation ratio	EML6 NELL1	5.21e-03	15	215	2	EFO_0007902
Disease	body weight	LRRC66 BRINP3 DIS3L2 ZBTB43 RGPD1 IRS1 NELL1 CPVL ARAP1 JADE2 CRTAC1 SBNO2 PPP1R3A NBAS TNNI3K AATK FIBCD1 PATJ	5.24e-03	1261	215	18	EFO_0004338
Disease	Congenital total cataract	GCNT2 NHS	5.93e-03	16	215	2	C0266539
Disease	phosphatidylcholine 38:6 measurement	SUGP1 DEPDC5	5.93e-03	16	215	2	EFO_0010388
Disease	Early infantile epileptic encephalopathy with suppression bursts	KCNA1 CASK	5.93e-03	16	215	2	C0393706
Disease	Squamous cell carcinoma of the head and neck	IRS1 CASP8 TNNI3K	6.48e-03	52	215	3	C1168401
Disease	calcium measurement	SIDT1 SERPINA1 COX5A KPNA1 NBPF3 JADE2 RGS12 THBS3 KCNT2 CELSR2 SND1	6.64e-03	628	215	11	EFO_0004838
Disease	alcoholic liver cirrhosis	SERPINA1 SUGP1	6.69e-03	17	215	2	EFO_1000802
Disease	Huntington's disease (is_marker_for)	CASP8 SIRT1 OPTN	6.84e-03	53	215	3	DOID:12858 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VSIYSGDESVASHFA	AZI2	26	Q9H6S1
GDESVASHFALVTAY	AZI2	31	Q9H6S1
TGETFDYSELASHVV	COL17A1	1051	Q9UMD9
STDHYIGFETDLQDL	BRINP3	481	Q76B58
DSDGHTDAFVAYFAD	BBS5	291	Q8N3I7
VYAEADSQESADHLA	PGM3	506	O95394
HVVSEFGDSYFEELR	ARHGEF25	261	Q86VW2
EDIYSETSGHFRDTL	ANXA10	141	Q9UJ72
LQESHEISFEAAFGY	CATSPERE	631	Q5SY80
SDISVSAAGFHLEYT	CSMD3	2031	Q7Z407
HEASIDLSAYIESGE	CEBPE	36	Q15744
HFEALADTGISSEFY	C8A	216	P07357
LYHSEAFTVNFGDTE	SERPINA1	161	P01009
FHVNTVTDDDYAGFI	COMP	586	P49747
HSVSEGVDFYSELRN	GSG1	311	Q2KHT4
FASDRDLGTDGEVHY	FAT4	3321	Q6V0I7
DYVTGVLHSGSADFE	ABCF3	21	Q9NUQ8
DSFYRTANSEHFEGE	ANKRD60	196	Q9BZ19
EFENVHFSYADGRET	ABCB6	591	Q9NP58
HFSYADGRETLQDVS	ABCB6	596	Q9NP58
SEAEVAELYFHDSAN	AKAP11	1836	Q9UKA4
EIFFHYSEFSGDVDS	CSDE1	541	O75534
SHGEAAAVDSEAVYQ	AP5Z1	376	O43299
SGVIYDSDESIHSDE	DMXL2	2471	Q8TDJ6
EEVDFYSFGVEARDH	CELSR2	571	Q9HCU4
TAYDLSVDTLDVHAD	AMPD2	466	Q01433
GAFYAEVEAHNTVTS	CDHR5	426	Q9HBB8
ILTEYGVDFSDFSSE	DIS3L2	336	Q8IYB7
DVYHTVDDDEAFSVD	PIK3AP1	511	Q6ZUJ8
YADEAEAAAESGTSA	C1orf115	41	Q9H7X2
LGTDSSDSDVDYDFL	CDH5	746	P33151
FKSAVHYDEESGSEE	ATG2B	1006	Q96BY7
HYDEESGSEEETLQY	ATG2B	1011	Q96BY7
SDTHDEGEVQAFYED	GRAMD1B	356	Q3KR37
EHYSNAGASLDESLF	AOX1	871	Q06278
IKVVDFGSATYDDEH	CLK1	321	P49759
FGSATYDDEHHSTLV	CLK1	326	P49759
FSAEVHGLESDTRYF	IGDCC4	906	Q8TDY8
SEIVEYEEDAHITFA	RANBP2	641	P49792
SFDSLDVYGQEESLH	RBM44	246	Q6ZP01
NSAEEFALYVVHTSG	RASSF2	216	P50749
LEEAGFHTVEAVAYA	RAD51	41	Q06609
SEIVEYEEDAHITFA	RGPD5	641	Q99666
SEIVEYEEDAHITFA	RGPD8	641	O14715
ISTIGELDHEESGFY	PCDHGA12	301	O60330
DVYRAGIATHFVDSE	HIBCH	206	Q6NVY1
LVYAEDASSDSTGAD	LACRT	16	Q9GZZ8
LEFVTEGSHFVEATY	MFN1	26	Q8IWA4
ILGSFDDYSSDEDSV	ACACB	166	O00763
SEEELTHIFGDLDSY	NET1	211	Q7Z628
EDSGFYDIDVEAHDG	PCDHGA4	341	Q9Y5G9
EGSEHLFDSFEPETY	DEPDC5	1451	O75140
ESSHEYYLTVEATDG	FAT1	3296	Q14517
ASLYVGDLHSDVTEA	PABPC4	11	Q13310
ATDADGSRSHAAVDY	DCHS1	2506	Q96JQ0
RADAGFVYSEAVASH	CASK	106	O14936
DLIEHYFGVEDDDSS	KPNA6	496	O60684
QQDGDEDSLVSHFYT	NUP98	646	P52948
HEFTDELTFSEALGA	KCND1	491	Q9NSA2
DSYTDFHIDFGGTSV	KDM7A	276	Q6ZMT4
YAHDGSDSTSDVAVL	FRAS1	1291	Q86XX4
SAVFETDGHLVTDSF	FRAS1	1791	Q86XX4
DYGLESEVAQHLAAT	GPD2	486	P43304
SSAVYFAEAEEAESH	KCNA1	341	Q09470
YHGDTSETFLVGNVD	METAP1D	186	Q6UB28
HSYADFSGATEVILE	NGLY1	601	Q96IV0
DIHHGDGVEEAFYTT	HDAC1	176	Q13547
GHYARTSLEDEEVFE	TRMU	126	O75648
GSVAESYDTESGFED	SBF2	791	Q86WG5
SHYVTETLSEEEAGF	GCNT2	81	Q8N0V5
AYEEIAATSSGQVFH	HMCN2	181	Q8NDA2
TDGTHTDFYVFPDTV	FREM2	1621	Q5SZK8
LLGDSAAIEEVYHSS	HPS4	561	Q9NQG7
ESSDDFGSQLRHDYV	BSN	801	Q9UPA5
FGSQLRHDYVEDSSE	BSN	806	Q9UPA5
SHDGTELLASYNDDD	DCAF8L2	431	P0C7V8
AHSVEYSIADSFEIE	CSRNP3	306	Q8WYN3
HGEESSFSDLSDYDH	FSIP2	5241	Q5CZC0
FTDDTHGYAVNEDDV	CPVL	161	Q9H3G5
VSLHFDTETDGYFSD	JADE2	741	Q9NQC1
LSLDLHFTDGDYSAD	FAM135A	111	Q9P2D6
HFTDGDYSADDLNAL	FAM135A	116	Q9P2D6
EETDYSALDGTINAH	FAM135A	1101	Q9P2D6
GSQVHYARSEDEDSL	GSX2	276	Q9BZM3
VAHDDIPYSSAGSDD	PCYT1A	166	P49585
VAHDDIPYSSAGSDD	PCYT1B	166	Q9Y5K3
YEGDEHGDTELDFSV	PLXNA3	751	P51805
HAGGVITEEDFSNYS	GGT7	341	Q9UJ14
QLDYSFGDHTSEAVR	PCDHGC5	276	Q9Y5F6
DSDQGANAEIEYTFH	PCDH1	306	Q08174
SHDGTELLASYNDED	DCAF8	396	Q5TAQ9
EEHVTTFEDEGSYII	FRYL	2571	O94915
EDITLDYSDVDSFTG	DEFB125	76	Q8N687
ENSTFDEFGHSINDY	DPP4	91	P27487
DGELEDTYHEFFVAS	TUBGCP3	436	Q96CW5
DYDSRTALHVAAAEG	GLS2	516	Q9UI32
HVVETFFGFDEESVD	JAKMIP1	436	Q96N16
HIVLEESTFFAEYEG	KCNT2	491	Q6UVM3
SFSASEDEGHREYQA	PHACTR2	426	O75167
LYTRDEHFAIAADSE	IRS1	86	P35568
HEAEVFLSTGSELVY	FAAP100	31	Q0VG06
TSNALSGYHVEDLDE	HELZ	146	P42694
SEEYEEALSLAHTYG	NBAS	536	A2RRP1
EYGESFIHSVAVSEV	PEG3	481	Q9GZU2
HSYFELESSGLRDEI	NELL1	111	Q92832
SGARAEEALSAHYSE	LRRC66	641	Q68CR7
YGSSHTDVIVTEDEN	ALDH18A1	691	P54886
AIDFEDSNTYEIHVD	PCDHA10	306	Q9Y5I2
TFDLGTDIFHTEEYV	PPP1R3A	91	Q16821
ARYESLHISDDVFGE	PGBD5	21	Q8N414
EAAYSLSEHVTGEEE	ITGA9	576	Q13797
FSVIFDTSHLSGEEE	ITGA9	721	Q13797
SAVYFAEVDEPESHF	KCNA10	391	Q16322
SSEHEGAYQDCEETL	KAT6A	1436	Q92794
YSLEEEHVGFSLDVD	NBPF3	521	Q9H094
HSFLEDLATYETAFE	NPAS4	751	Q8IUM7
AGTESAHYSVAEETE	PCDHB14	26	Q9Y5E9
AHYSVAEETEIGSFV	PCDHB14	31	Q9Y5E9
ASEIVEYEEDAHVTF	RGPD3	641	A6NKT7
DIFESVHSSYNVATG	ATMIN	516	O43313
SYGASGQFTHEFDEE	HLA-DOA	41	P06340
TGVAFELRDSSAYHV	DNAAF3	236	Q8N9W5
DDTHAYNVADFESLS	COL12A1	1351	Q99715
SADDHYEFATKGSQE	FOXN3	361	O00409
YFHEEDESSFQLVDT	EIF3D	71	O15371
EGYDFHSSSEFEIVK	ACTR1A	201	P61163
VGSFYEAHDTVDLTS	ADPRS	36	Q9NX46
DAGALTTTFEELHFE	CASP8	266	Q14790
LHVDLEDFENGTAYA	FIBCD1	331	Q8N539
EFDVTGNTFEAHIYS	KNDC1	111	Q76NI1
RALDIYSAVDDASHE	CARTPT	36	Q16568
YGVAVTDVDHDGDFE	CRTAC1	56	Q9NQ79
AVGSSEHTVDFYDLT	EML6	1786	Q6ZMW3
VVDFGSATYDDEHHS	CLK4	321	Q9HAZ1
SEDIFVHVSDIEGEY	CSDC2	91	Q9Y534
DVSDHLFYSFERGNE	CELSR3	1201	Q9NYQ7
TSFSGVDEHAPISYE	FAM161A	66	Q3B820
ASSYFIDAATVDDSG	FCGR3A	71	P08637
YSHGSQETDEEFDAR	COX5A	41	P20674
EAESLGHSSYSVDDV	DLEC1	726	Q9Y238
YTTAAHFAEFAGEEA	RYR1	496	P21817
ITSDFHQYDTGFDLD	RYR2	1446	Q92736
SVFNVHTGDELLSYE	PHKB	151	Q93100
GSVYHLTDEDFDQFV	PDIA5	276	Q14554
ASEIVEYEEDAHITF	RGPD1	631	P0DJD0
DVFGQTAEDYAVSSH	POTEA	261	Q6S8J7
GSETTGVAIFDYEHL	ADHFE1	191	Q8IWW8
SRSADGAKNYFEHEE	OPTN	216	Q96CV9
ELGHHIYSSDSSFEV	PDHA2	361	P29803
SEGAHSYEFFQTSEL	MROH5	436	Q6ZUA9
SDETAEDVLTVAYEH	KCNAB3	106	O43448
FFSSADGYHLIDAES	NRK	1426	Q7Z2Y5
YSPSDEELHRFSDEG	NR6A1	351	Q15406
VYVESSSGSEHEDHL	GPRASP1	291	Q5JY77
FDVTDGVNTLTDHYF	FREM3	1401	P0C091
EDSEVYNFTLHAGDE	GAREM2	136	Q75VX8
ASEIVEYEEDAHVTF	RGPD4	641	Q7Z3J3
SDHSASLTDAGEVYV	SERGEF	221	Q9UGK8
RYEQDSGHDSGSEDA	TRIM36	611	Q9NQ86
GFSSREYVLLHESSD	SNIP1	361	Q8TAD8
AYFSDLEAEAEATSG	AATK	996	Q6ZMQ8
SAYEEGESFVGDHER	NHS	526	Q6T4R5
SFEEEHISFALYVDN	NBPF26	866	B4DH59
FSYDVDSDHVDIISD	MKLN1	486	Q9UL63
DFTALGFSDVDHTYA	MKLN1	691	Q9UL63
FHKYEEEEDVETGAS	MRM3	316	Q9HC36
EHYFGTEDEDSSIAP	KPNA1	501	P52294
IVHEDFNTLSYDSDI	OVCH1	651	Q7RTY7
HDGYISQEDFESIAA	RASGRP3	436	Q8IV61
ESETESFYGFEEADL	POGZ	1391	Q7Z3K3
GIFTFSAAVYSVEHD	KCNV2	421	Q8TDN2
YAEDLSHVASGESVD	SMG1	371	Q96Q15
EEGFTEEGASYFIDH	PLEKHA7	61	Q6IQ23
EADEELTVAYGYDHS	SETD7	326	Q8WTS6
DTHFYPLEEGSTSLD	SHLD1	166	Q8IYI0
IFHGAEVYSDSEDDV	SIRT1	651	Q96EB6
TDDLHFYVQDVETGT	SND1	691	Q7KZF4
SGETAKTDASFHAYD	SLC12A1	76	Q13621
EEAEELGHTETYADY	SBNO2	191	Q9Y2G9
AGHTVVVDSVEYDFH	ADSS2	66	P30520
YSHEEDIDSAIEVFT	SRP72	416	O76094
DSYENLSADGEVLHT	TNS3	331	Q68CZ2
SVHFGEDGASYEAEI	RHPN1	131	Q8TCX5
YTEHFGKSVENDSDE	SIX6OS1	396	Q8N1H7
AHYTGTASFIIEDDD	L3HYPDH	331	Q96EM0
HYRDEDGDLVAFSSD	SQSTM1	66	Q13501
TGESLYGDFTEALEH	TENT5B	246	Q96A09
HSDDAGDYEQLFSST	SLX4	976	Q8IY92
EAESALEAAHYFTED	TBC1D9B	936	Q66K14
THGFEHTFEVYTEGE	ARAP1	811	Q96P48
EEGASDSAEFHYTRP	ZBTB43	216	O43298
HGYDSDEEVDSELGT	SUGP1	481	Q8IWZ8
SDIHDFEYDKSLGST	PIK3R4	21	Q99570
DLDAHGIIFTEDYRT	STK19	206	P49842
AEHSTVITFLDYHDG	VPS13A	2396	Q96RL7
VDFLSNEGHIYSTVD	RPA2	246	P15927
YSEEALFVASFESEG	RASGEF1A	446	Q8N9B8
DSVFSIGLESHDDFA	RGS12	206	O14924
DTDDDFRHLLGAYVS	RNF112	376	Q9ULX5
SAHAGTYEVRFFDEE	SSR4	96	P51571
ESRAHSGFYQDDSLE	ILDR2	461	Q71H61
GVEVDSFDGHHYISS	PATJ	571	Q8NI35
YVVGTAHFSDDSKRD	TRABD	76	Q9H4I3
DDGDDNTLYHRGFTE	STX16	206	O14662
ADFDHVYSGVVNLST	SIDT1	46	Q9NXL6
DVEHTGATSEFYDKF	UBE4B	976	O95155
DEAVFAQYDSFHVDS	TNXB	4126	P22105
VHRETEDVDYGETDF	TMEM40	16	Q8WWA1
DGDLAHEFYEETIVT	TUSC2	56	O75896
EELHTNSAEGEYSAL	UBR1	1526	Q8IWV7
DEDKESTFGYVHGVS	ATP6V1A	11	P38606
YLASGDFGHTVDSVE	SPTB	2031	P11277
FHVNTVTDDDYAGFL	THBS3	781	P49746
DHALDSQEYEGLFLS	CAD	206	P27708
SAGYFIHDTVDIVAS	TLCD1	91	Q96CP7
LADGHLSDSDDYSEL	ZNF839	156	A8K0R7
ATVSGYFVSIDAHAE	TMED2	16	Q15363
VESDVGDSFYIRTHF	TJP1	511	Q07157
HEESTEGEADHSGYA	UFD1	206	Q92890
LLRGDYSHETASTDD	WDR93	586	Q6P2C0
ESFNIDHYRSSLGEE	VPS13B	1376	Q7Z7G8
LTGVDEAYTLEEFQH	XPNPEP3	176	Q9NQH7
FTTVVADTGDFHAID	TALDO1	21	P37837
TVIHSGDYFLFESDS	PIEZO1	1411	Q92508
ADLLTDHEEGYVTFE	ZNF419	16	Q96HQ0
LYEDGHAVVADFGES	TNNI3K	596	Q59H18
TYFQGDISSVVDEHF	VGLL1	31	Q99990
DSIKSHVSYETEGFE	ZNF106	681	Q9H2Y7
HVSYETEGFESASLD	ZNF106	686	Q9H2Y7
FYQTLAGVTHLEESD	USP32	181	Q8NFA0
VYHSEDLENSVGELS	KIAA0586	1311	Q9BVV6
DEESHYAVGAAGESV	RNF39	306	Q9H2S5
EENEIYGFDLASSHL	VPS13D	1356	Q5THJ4
TFIGDGDTYTLVEHS	LIMK1	116	P53667
VAFDLATHRGYDSDN	MMUT	136	P22033
TEADAGHTEFTDEVY	MYOF	921	Q9NZM1
FRSSEEEHEFSAADY	MYOM3	51	Q5VTT5
EEHEFSAADYALAAA	MYOM3	56	Q5VTT5
DFSEADLVDVSAYSG	PPP1R9B	386	Q96SB3
LEGDAHVDSTTYDGT	NFKB1	706	P19838
YDENEDDLVSHVDGS	NECTIN3	526	Q9NQS3